ID;Term;Depth;IC Nuno;IC zhou;IC sanchez;IC resnik;IC RZ;IC Rnormalized;IC Nuno org;Annotated Genes Set number
GO:0045401;positive regulation of interleukin-3 biosynthetic process;8.0;1.0;0.875;9.628524252492122;833.6113263844036;9.777073627680469;0.027900220892599446;0.875;[SYK]
GO:0090330;regulation of platelet aggregation;9.0;0.8259837884571596;0.8092325194088689;9.533214072687796;97.23557350837086;6.943860283624253;0.0032543871389904074;0.7513499630073597;[LYN, CEACAM1, SYK, PDPN, PRKCD, CD9, PRKCQ]
GO:0007257;activation of JUN kinase activity;14.0;1.0;0.9759193652572005;9.628524252492122;8640.54909511404;6.088194173566533;0.2891914022241413;0.7872698984233759;[TNFSF11, CCL19, MAP4K1, SYK, CD40LG, MDFIC, PKN1]
GO:0051092;positive regulation of NF-kappaB transcription factor activity;12.0;0.9326813400603323;0.9144609826203107;9.587702257971866;279.4401483168805;4.8283137373023015;0.009352610284359957;0.6950405016553352;[TNF, CLU, PYCARD, TNFSF11, TRIM25, PRKCH, BTK, PRKCQ, ADAM8, S100A8, CARD11, TNFRSF11A, PRKCZ, NLRP3, S100A12, TGFB1, NFKB1, NFKB2, MYD88, CD40, ITGB2, CD36, CHUK, IL18, IRAK3, TRAF1, GREM1, PSMA6, IL1B, TLR6, TLR4, LTF, TLR2, NLRC4, NOD2, CD40LG]
GO:0060369;positive regulation of Fc receptor mediated stimulatory signaling pathway;7.0;0.9326813400603323;0.8172600352873667;9.577230958104572;294.1477435792768;8.390779266560578;0.009844860261815976;0.7800242071602487;[LYN]
GO:0045646;regulation of erythrocyte differentiation;7.0;0.7980440201809971;0.7499413753476991;9.34084218004034;77.59787612007705;5.9928839937622085;0.002597131080184449;0.6573957313958061;[SPI1, HMGB2, GATA1, ETS1, INPP5D, NCKAP1L, HOXA5, LYN, MED1, KLF13, ISG15, INHBA, MAPK14]
GO:0051090;regulation of DNA binding transcription factor activity;10.0;0.7192862368539868;0.7748841302879137;9.223059144383958;255.33763090554476;3.793137346993279;0.00854592071745993;0.6092222321850824;[PHB2, AKT1, TNFSF11, CYP1B1, TRIM25, PRKCH, SFRP4, BTK, SIK1, PRKCQ, TRIB1, BEX1, TWIST1, PRKCZ, PKHD1, NHLH2, S100A12, HMOX1, FZD1, JUN, JUP, ID1, EZH2, CD40, CD36, HAVCR2, IL10, EDN1, SYK, ANXA3, NFAM1, IL18, FOS, SIRT1, PSMA6, HCK, IL1B, KIT, TLR6, SGK1, TLR4, TLR2, FLNA, NR1H4, POU4F1, NLRP12, CD40LG, FOXA2, TNF, CLU, PYCARD, MEN1, FANCD2, ADAM8, S100A8, CARD11, TNFRSF11A, NLRP3, TGFB1, WFS1, NFKB1, NFKB2, NFKBIA, IL6, COPS5, JMY, CCDC22, MYD88, CREBZF, ITGB2, TNFAIP3, MYOCD, CHUK, DDX58, IRAK3, TRAF1, GREM1, XCL1, LTF, NLRC3, NLRC4, NOD2, KLF4]
GO:0006957;complement activation, alternative pathway;8.0;1.0;0.875;9.628524252492122;200.06168254027287;7.212124270218933;0.006695884470798082;0.7438283705770736;[CFD, C3, CFH, C7, CFB]
GO:0002479;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent;6.0;1.0;0.8231203125901445;9.628524252492122;33.24930607151726;6.518977089658987;0.0011128243517809471;0.6565011041187423;[CHUK, ITGB5, CD36, FCGR1B]
GO:2000010;positive regulation of protein localization to cell surface;7.0;1.0;0.8509193652572005;9.628524252492122;73.70707873031733;7.004484905440688;0.002466909593039506;0.7091290490632969;[FCER1G, TNF, AKT1, CD247]
GO:0065003;protein-containing complex assembly;4.0;0.45485133202666184;0.4774256660133309;6.058991556010752;36.471478728154885;2.4440506132939883;0.0012206675708314864;0.3749888620238313;[, NUP107, PRKACB, CLDN3, PADI4, PDGFC, ABCA1, JUP, FN1, COL1A1, COL1A2, HLA-DRB1, ACHE, DPYS, ARHGAP6, CHAF1B, CHAF1A, KCND2, ARG1, F5, SLC7A7, SLC7A9, KCNA5, CENPA, HLA-DMA, HLA-DMB, DMD, CENPE, CENPF, CENPH, CENPI, CENPK, CENPL, CENPM, GOPC, CENPN, CENPO, KCNG2, GMNN, RUVBL2, RUVBL1, OLFM4, BLM, UQCRB, LIN7A, ACAT1, CXCL12, HLA-DRA, LRRK2, ALAD, VBP1, NDUFC2, ACPP, BDP1, BIRC3, NDUFB7, NDUFB6, HM13, NDUFB4, NDUFB3, NDUFB2, NDUFB1, CCL5, EIF4H, NDUFA8, NDUFA7, NDUFA6, NDUFA3, NDUFA2, IL2RB, CD247, EIF3D, CCNH, PRF1, IKZF1, TCL1A, SNRPD2, SNRPD1, TNFSF11, FBXO5, SNRPD3, HNF1B, MIF, KCTD12, KCTD15, TGFA, PTK2, CD40, CTSZ, CD3G, CD3E, CD3D, CCT3, CCT2, FCER1G, YAP1, NAPA, MIS12, CAPG, CCT8, CD74, GCH1, RPA1, RPA3, NDUFAB1, NDUFB10, NDUFB11, TCF7, RASGRP1, CCNB1, H1FX, ECT2, CAV2, UBE2C, CAV1, HMGA1, VIL1, NASP, TCF4, HMGB2, TNFAIP3, LAMC1, NUP62, GREM1, NDUFS8, NDUFS7, NDUFS6, NDUFS4, NDUFS3, NUP54, FBP1, TAF9, SAMHD1, RRM1, EGF, MX2, SOD2, TTC19, TEK, CDA, BIN2, NUP205, PRKCZ, ACMSD, HMOX1, NCKAP1L, EHD3, SERPINA1, TK1, BRD2, GSN, GTF2H1, TNF, CLU, DACH1, MEN1, TLE4, SNRPG, SNRPE, SNRPF, ITPR3, NACC2, LSM3, HOPX, CDK1, EMILIN1, ADSL, VWF, TRAF1, PTBP2, MCM2, NLGN1, NLRC4, NOD2, PLN, WASF3, PML, MARCKS, RAD51, P2RX1, IMPDH2, PPP2R1A, MCCC2, COX7A2L, TLN1, MGST1, CD79B, CD79A, VASP, AHCTF1, RAD51C, UQCR10, CTNNA1, NDUFA11, KNTC1, CHRNB4, NCF1C, ADRB2, NLRP3, MYH11, TGFB1, EIF2S1, H2AFX, AXIN2, DNM2, TGFBR3, COL6A2, COL6A1, COLEC12, CAMK2D, HIST1H2BK, LEF1, HSPD1, REPS2, RBMX]
GO:0007263;nitric oxide mediated signal transduction;7.0;0.9326813400603323;0.8172600352873667;9.510741216835738;27.814661162170232;6.832634648514029;9.309316775279788E-4;0.7003406189322132;[FPR1, CD36]
GO:0007265;Ras protein signal transduction;7.0;0.7586651285174919;0.7302519295159464;8.935377071932177;27.526979089716047;4.2636448815154875;9.213032174599934E-4;0.5689623627776663;[CYFIP1, CELSR1, EPS8, GRAP2, ARHGDIA, ARHGDIB, RAB32, DOK2, DOK3, AGTR1, IQGAP3, RASGRP1, JUN, HACE1, PLK2, DHCR24, COL1A2, BCL6, LAT, CDKN1A, ARHGAP6, ARHGAP4, RAC2, ARHGEF12, CHUK, RHOG, RHOH, RAB33B, CCNA2, RHOU, RAB21, PAK1, PDPN, EPS8L1, EPS8L3]
GO:0006974;cellular response to DNA damage stimulus;4.0;0.5696777571895439;0.534838878594772;7.469040003138749;28.997869804256865;3.161008442547652;9.705326059599744E-4;0.4116541187538124;[SMC3, AKT1, CDCA5, HMOX1, SFN, BARD1, LYN, PLK2, PLK1, CDKN1A, BTG2, CHAF1B, CHAF1A, CTLA4, ACTL6A, SIRT1, UNG, USP1, PMS1, GTF2H1, FMR1, TNF, PYCARD, RUVBL2, RUVBL1, MACROD2, MEN1, MSH6, MSH2, BLM, CUL5, FOXO1, MAP2K6, FANCI, FANCG, COPS5, BCL6, CNOT3, BCL3, CDK1, BCL2, BCL2L1, MCM7, EXO1, RFC5, RFC3, RFC4, RFC1, RFC2, SMC1A, TNFRSF1B, TFDP1, DTL, PPP1R15A, RBBP8, POLR2E, E2F1, POLR2I, POLR2J, E2F7, POLR2K, POLR2L, DONSON, PML, RAD50, RAD51, MNDA, SMARCAL1, CCNH, CHEK1, TRIM25, SOX4, ESCO2, MIF, EPHA2, POLA1, TOP2A, FEN1, SUV39H1, BRCA1, BRCA2, PARP9, RAD51C, SGK1, YAP1, PCNA, RAD54B, RAD54L, GINS2, RPA1, MLH1, RPA3, NEDD4, DCLRE1A, LIG1, FANCD2, PSMD14, CCNB1, HMGA1, ISG15, JMY, TOPBP1, H2AFX, IRF7, BCL2A1, TAF9, POLD3, POLD1, MAPK14, POLE2]
GO:0001954;positive regulation of cell-matrix adhesion;6.0;0.8653626801206646;0.7558016526504768;9.34084218004034;50.25702962731741;5.926926025970411;0.0016820575532361247;0.6262235851885184;[NRP1, THY1, PRKCZ, EPB41L5, CCR7, CD36, JUP, CCL21, CEACAM6, NINJ1, TEK]
GO:0006606;protein import into nucleus;9.0;0.8933024483968273;0.8428918493787028;9.551563211355994;277.5355368998559;5.288437257948329;0.009288864654271135;0.6666915524892495;[NUP107, CSE1L, NUP62, NUP133, SYK, TSC2, MMP12, NUP54, NUP85, NUP88, RANBP2, RANBP1, NUP155, RANBP6, PML, NUP35, RAN]
GO:0045780;positive regulation of bone resorption;7.0;1.0;0.8509193652572005;9.628524252492122;82.90338698468558;6.943860283624253;0.002774701754173115;0.7060287030842711;[TFRC, SYK, CA2, SPP1, TNFSF11, ADAM8, TNFRSF11A, TMEM64]
GO:0048013;ephrin receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;31.002284443533863;5.395046993006588;0.0010376185600805164;0.6509029541176994;[EPHB2, EPHB1, AP2M1, MMP2, MMP9, EPHA3, EPHA2, SDC2, PAK1, FYN, LYN, PTK2]
GO:0010668;ectodermal cell differentiation;4.0;1.0;0.75;9.628524252492122;21.066225782797595;8.390779266560578;7.050676185779127E-4;0.6791048419030481;[ITGAM]
GO:2000363;positive regulation of prostaglandin-E synthase activity;6.0;1.0;0.8231203125901445;9.628524252492122;43.017486512842105;8.67846133901236;0.001439756560360439;0.7669372290569613;[ITGAM, ITGB2, NOD2]
GO:2000121;regulation of removal of superoxide radicals;7.0;0.8259837884571596;0.7639112594857803;9.4949928598676;93.21217700056023;7.474488534686424;0.003119727678695759;0.7331650565203278;[GCH1, CD36, TNF]
GO:0018149;peptide cross-linking;7.0;0.6007507099811141;0.6512947202477576;8.117066748418225;151.15475272427284;5.69953618377475;0.005059013543235805;0.6423939107509793;[DSP, ANXA1, EPB42, FN1, BGN, F13A1, THBS1, DCN, COL3A1, SPOCK3]
GO:0010543;regulation of platelet activation;8.0;0.7866048967936545;0.7683024483968273;9.510741216835738;81.8829764000265;6.343086423195323;0.0027405495302144796;0.6993857346658935;[LYN, PDGFRA, FCER1G, SYK, TXK, PRKCD, PDGFA, SELP, THBD, CEACAM1, PDPN, CD9, PRKCQ, TLR4]
GO:0070508;cholesterol import;8.0;1.0;0.875;9.628524252492122;77.49126092049113;7.9853141584524145;0.0025935627654017587;0.7833693374183408;[CD36]
GO:0045429;positive regulation of nitric oxide biosynthetic process;8.0;1.0;0.875;9.628524252492122;658.6394256443023;6.166155715036245;0.02204406883931546;0.6903374900225189;[ITGB2, PTGS2, TNF, CLU, KLRK1, AKT1, CD36, EDN1, AGXT2, KLF4, DNM2, IFNG, IL1B, PTX3, TLR6, TLR4]
GO:0090314;positive regulation of protein targeting to membrane;10.0;0.9326813400603323;0.8815816818910864;9.587702257971866;497.0805077511855;6.343086423195323;0.016636837251019197;0.7396267465268138;[, ITGAM, ITGB2, PDZK1, PAK1, FYN]
GO:0038095;Fc-epsilon receptor signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.5544162803384;78.4757768553383;4.989581884898423;0.002626513627734276;0.6301674496329921;[ITK, GRAP2, FCER1A, FCER1G, CHUK, SYK, FOS, GAB2, VAV1, LAT2, BTK, PRKCQ, LCP2, CARD11, PAK1, IGKC, IGLV1-44, PLCG1, LYN, JUN, NFKB1, NR4A3, IGKV3-20, LAT]
GO:0043123;positive regulation of I-kappaB kinase/NF-kappaB signaling;8.0;0.8933024483968273;0.8216512241984136;9.517298617381897;239.11083947336738;4.629579150867016;0.008002824611389124;0.6117568930727868;[IL1RN, GOLT1B, TNF, LGALS1, AKT1, TNFSF11, TRIM25, WLS, PRKCE, F2R, CARD11, S100A12, HMOX1, ECT2, NDFIP2, PLK2, TNFRSF10B, CCDC22, MYD88, ECM1, CD40, SECTM1, FASLG, NUP62, CCR7, CD36, CHUK, ZDHHC17, IL1B, TLR6, LTF, BIRC3, NOD2, FLNA, FYN, CCL19, CD74, CCL21, CARD9, CD4, LTBR]
GO:0038094;Fc-gamma receptor signaling pathway;8.0;0.9326813400603323;0.8413406700301662;9.5544162803384;78.4757768553383;4.857092701852345;0.002626513627734276;0.6233919466506386;[CYFIP1, CD3G, IGHG1, FCGR3A, FCGRT, FCER1G, SYK, PRKCE, PRKCD, VAV1, FGR, HCK, CLEC4D, PAK1, IGKC, IGLV1-44, NCKAP1L, FYN, PLCG1, LYN, PTK2, FCGR2A, CD247, FCGR2B, IGKV3-20]
GO:0046513;ceramide biosynthetic process;8.0;0.811012628672052;0.780506314336026;9.474373572664863;443.75121156962103;6.015873511986907;0.014851953701072812;0.6826520511697386;[GAL3ST1, SGMS1, P2RX1]
GO:0038096;Fc-gamma receptor signaling pathway involved in phagocytosis;10.0;1.0;0.9152410118609203;9.628524252492122;384.64074149301706;4.886724499458715;0.01287357946357817;0.6651483300191682;[CYFIP1, CD3G, IGHG1, FCGR3A, SYK, PRKCE, PRKCD, VAV1, FGR, HCK, PAK1, IGKC, IGLV1-44, NCKAP1L, FYN, PLCG1, LYN, PTK2, FCGR2A, CD247, FCGR2B, IGKV3-20]
GO:0046638;positive regulation of alpha-beta T cell differentiation;10.0;0.7671156992804218;0.7987988615011312;9.488762310116963;1285.3660192826185;5.970411137910149;0.04302004391107474;0.7205681151061569;[CD86, CD83, CD80, IHH, PRKCZ, HLX, MYB, NLRP3, NCKAP1L, CCL19, IL12RB1, ANXA1, SYK, IL18, ZAP70, IFNG, IL23A, RARA]
GO:0045425;positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process;8.0;1.0;0.875;9.628524252492122;833.6113263844036;9.083926447120524;0.027900220892599446;0.839552420951524;[SYK, CD80]
GO:0002223;stimulatory C-type lectin receptor signaling pathway;11.0;1.0;0.9324289523296623;9.628524252492122;628.1099736002739;5.618190544320798;0.02102227555412486;0.7197434780388068;[CLEC10A, ICAM2, ICAM3, PAK1, KLRK1, MUC13, FYN, MUC15, PRKACB, LYN, FCER1G, CHUK, SYK, CARD9, PRKCD, NFKB1, MUC3B, CLEC4D, CARD11]
GO:0042953;lipoprotein transport;8.0;1.0;0.875;9.628524252492122;68.44752614357394;7.138016298065211;0.0022908771012512216;0.7400384854347593;[MSR1, CUBN, LRP1, CD36, LRP2, ZDHHC17]
GO:0002576;platelet degranulation;8.0;1.0;0.875;9.628524252492122;39.85546922145481;4.956792062075433;0.0013339266872485146;0.6284905765689417;[ORM1, ECM1, SERPINA1, SPARC, PROS1, ITGB3, ITGA2B, SERPINE1, F13A1, CTSW, CLU, LAMP2, TIMP3, CD36, TIMP1, VWF, ACTN1, APLP2, ANXA5, ACTN4, F5, MMRN1, PECAM1, SERPING1, TLN1, VCL, CFD, STXBP2, PDGFA, THBS1, PSAP, FLNA, A2M, LYN, TGFB2, TGFB1, EGF, PCDH7, FN1, LHFPL2, PPBP, SELP, TF, CD9, PF4]
GO:0007229;integrin-mediated signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;5.311165509025885;8.87013979980389E-4;0.5947335637161829;[NRP1, ITGAM, ITGB5, ITGB4, ITGB3, ITGA2B, ITGB2, ITGAL, CTGF, ADAMTS1, ITGAX, ITGB8, ITGB7, ITGB6, FCER1G, SYK, ITGA4, VAV1, FGR, HCK, CEACAM1, TYROBP, ADAM9, ITGA7, TLN1, CDH17, TXK, THY1, PTK2, COL3A1, ZYX, PLP1, LAT]
GO:0034605;cellular response to heat;5.0;0.8436909121759173;0.712086467948879;9.260799472366804;50.43140892920004;5.666199763507158;0.0016878938715389536;0.5800107312719123;[CDKN1A, PTGS2, THBS1, HMOX1, LYN, HSPA6, EIF2S1, CXCL10, IL1A, TFEC]
GO:0046641;positive regulation of alpha-beta T cell proliferation;10.0;0.8653626801206646;0.8479223519212526;9.54628615425515;937.8544877713971;6.8867018697843045;0.03138914569146771;0.7674272657460779;[BLM, SYK, IL18, CD3E, ZAP70, IL23A, CD28, XCL1, CCR2]
GO:0019221;cytokine-mediated signaling pathway;6.0;0.6039883530135606;0.6251144890969248;7.604142487995313;26.50247477320489;3.309374901576116;8.87013979980389E-4;0.49236189895841853;[AKT1, JUNB, PRKCD, FPR1, GATA3, FLRT2, HMOX1, HLA-DQA2, HLA-DQA1, HLA-DRB4, FN1, COL1A2, HLA-DRB1, CDKN1A, LRRC4, TIMP1, JAK3, HLA-DPA1, ANXA1, SERPINB2, IFNGR1, GPR35, IFNGR2, BGN, FOS, SIRT1, F3, FCER2, PLCB1, HLA-DQB1, CCL13, LRRC19, PTAFR, PTGS2, ALOX5, STAT4, CCL19, CCL18, IL12RB1, IL12RB2, CCL23, CCL21, CCL20, HLA-DPB1, PF4, CSF3R, F13A1, IL5RA, RORA, CXCL13, TNF, PYCARD, IGHG1, IL13RA2, IL13RA1, IFNA14, CISH, IFNA16, IFNA10, CSF1R, TNFRSF11A, FOXO1, SOCS2, TNFRSF17, IFNA21, TNFRSF10C, TNFRSF10B, NFKB1, CXCL10, CXCL11, CXCL12, BCL6, LCN2, BCL2, HLA-DRA, MYD88, BCL2L1, CIITA, ITGAM, ITGB2, PIK3CD, FASLG, TNFSF13B, ITGAX, CHUK, TNFRSF1B, IL3RA, XCL2, XCL1, BIRC5, LCP1, BIRC3, CX3CR1, NOD2, IL2RG, CCL8, CCL7, CCL5, CCL4, IL21R, CCL2, CCL1, FYN, FCGR1B, PML, KLF6, IL2RB, PTPN6, IL1RN, IFI30, IFIT1, IFIT3, IFIT2, TNFSF11, TRIM25, RSAD2, ACSL1, IL1R1, IL1R2, FLT3LG, MIF, EREG, IFI27, IL23A, TWIST1, INPP5D, CCR10, CCR1, EGR1, TNFSF14, TNFSF12, TNFSF13, LIF, PPBP, SDC1, CD27, IFNA5, IFNA4, IFNA7, CD40, TNFRSF13B, IFNA2, IFNA8, CCR9, CCR7, CCR6, CD36, CCR5, CCR2, IL10, SYK, IL18, GP1BA, GAB2, IL17RB, VAV1, HCK, IL1A, CEACAM1, IL1B, KIT, RHOU, CXCR5, IFI6, CXCR4, CXCR6, CXCR1, CXCR3, CXCR2, IL32, CD74, IL33, PODN, CD40LG, IL18R1, IL17A, CD86, CD80, MPL, IL18RAP, CCRL2, IL6R, PRTN3, CSF2RB, CSF2RA, TGFB1, VCAM1, ISG15, NFKBIA, IL6, IL7R, CXCL6, CXCL9, CXCL1, CXCL3, CXCL2, CXCL5, GHR, LRRTM4, MMP1, MMP2, IRAK3, MMP9, DCN, IFNG, OAS1, OAS3, LTA, IRF7, LTB, CAMK2D, SAMHD1, NCAM1, MX2, SOD2, CD4, LTBR]
GO:0001805;positive regulation of type III hypersensitivity;11.0;1.0;0.9324289523296623;9.628524252492122;1205.6585476054483;9.083926447120524;0.04035230656610712;0.8969813732811862;[FCER1G, BTK]
GO:0033630;positive regulation of cell adhesion mediated by integrin;5.0;0.9326813400603323;0.7565816818910864;9.4949928598676;34.61675044652454;6.943860283624253;0.0011585914843924019;0.6453503496879909;[TGFB2, SFRP2, SYK, CCL21, CCL5, ADAM9, NCKAP1L, PTPN6, CXCL13]
GO:0033198;response to ATP;6.0;0.9326813400603323;0.7894609826203107;9.56398573135455;115.93137747960115;6.375876246018314;0.0038801188727762915;0.6491829203200885;[TRPC3, PTGS2, SLC8A1, P2RX5, SELL, P2RX1, IL1B]
GO:0050904;diapedesis;6.0;0.8933024483968273;0.7697715367885581;9.510741216835738;29.137022145890857;8.390779266560578;9.751899096054872E-4;0.7522251544931926;[ITGA4, PECAM1]
GO:0060252;positive regulation of glial cell proliferation;9.0;0.8933024483968273;0.8428918493787028;9.587702257971866;465.4406966640378;7.292166977892469;0.015577881247913653;0.769162383550154;[LYN, PRKCH, MYB, LTA]
GO:0090200;positive regulation of release of cytochrome c from mitochondria;9.0;1.0;0.896240625180289;9.628524252492122;472.23248408711356;6.409777797693995;0.015805196260752157;0.7240369598395108;[BIK, PLAUR, MMP9, PYCARD]
GO:0038083;peptidyl-tyrosine autophosphorylation;10.0;1.0;0.9152410118609203;9.628524252492122;522.6399477532146;5.905872616772578;0.017492288705884526;0.7172676121338334;[BLK, ITK, TXK, SLA2, GRAP2, FYN, CSK, JAK3, LYN, SYK, MATK, BMX, PTK2, FGR, ZAP70, HCK, LCK, FES, BTK]
GO:1904646;cellular response to amyloid-beta;7.0;1.0;0.8509193652572005;9.628524252492122;273.93391051768003;6.518977089658987;0.009168321460513012;0.6843001567857983;[LRP1, FPR2, ADRB2, GRM5, CD36, TLR6, FCGR2B, TLR4]
GO:0001812;positive regulation of type I hypersensitivity;11.0;1.0;0.9324289523296623;9.628524252492122;1109.5695898802176;9.083926447120524;0.0371362956254912;0.8969813732811862;[FCER1G, BTK]
GO:0002902;regulation of B cell apoptotic process;9.0;0.7369933605727446;0.7647373054666613;9.117698628726131;22.875998380894767;6.8867018697843045;7.656390787466303E-4;0.7484268790654467;[LYN, IL10, CD74, MIF, AURKB, BCL6, BTK]
GO:0016064;immunoglobulin mediated immune response;6.0;0.7586651285174919;0.7024528768488905;9.040737587590003;30.584352397600135;7.069023426578259;0.0010236307506175364;0.6846304993685643;[CD74, FCER1G, PRKCD, EXO1, INPP5D, BCL3, IRF7, TLR8, CD27, FCGR2B, IL13RA2, HLA-DQB1]
GO:0001934;positive regulation of protein phosphorylation;9.0;0.5833093054345528;0.6878952778975655;8.604019935977734;663.1129447749842;2.9039097934679514;0.02219379349871355;0.5447467070638558;[, PHB2, AKT1, PROK2, PRKACB, PRKCE, PRKCD, PRKAR1B, FPR1, PDGFA, FPR2, SLC30A10, IQGAP3, GATA1, PRKCZ, C3, PRKAR2B, PDGFD, PDGFC, S100A12, NCKAP1L, ELANE, LYN, FZD1, JUN, ACE, FZD5, PLK1, FZD8, CDC6, AZU1, NOX4, NOX1, EZH2, CDKN1A, TIMP2, HAVCR2, GPR37, FCRL3, SIRT1, DUSP6, CKS2, PLCB1, HBEGF, ENG, CCL13, FAM129A, PTGS2, GPNMB, NTF3, CCL19, CCL18, CCL23, CCL21, CCL20, CARD9, CENPE, PKN1, CCNT2, FMR1, TNF, CLU, CTGF, PYCARD, IFNA14, MAP2K2, IFNA16, IGFBP3, F2R, ADCYAP1, ADAM9, ADAM8, IFNA10, CSF1R, TNFRSF11A, PSAP, DRD4, IFNA21, MAP2K6, TNFRSF10B, DAB2, PTPRC, CDK1, BCL2, CSPG4, LAT, LRRK2, ITGB3, TREM2, PTPN22, CYR61, XCL2, XCL1, LCP2, NOD2, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, FYN, CSK, TIE1, RAD50, FCGR2B, IL1RN, CCNH, TCL1A, EDNRB, TNFSF11, EPHB2, EPHB1, ACSL1, SLC11A1, FLT3LG, MIF, EREG, SFRP2, IL23A, EPHA3, EPHA2, TGFA, SLAMF1, CCR1, EGR1, LIF, PTK2, MARCO, CD27, CALM3, CD24, IFNA5, IFNA4, NRP1, IFNA7, CD40, IFNA2, CD3E, IFNA8, CCR7, CD36, MAP4K1, EDN1, SYK, STRADB, IL18, PARP9, MDFIC, BANK1, IL1B, KIT, TLR6, TLR4, CXCR4, GNAI2, PAK1, CD74, CD40LG, CAMK1, CD80, IL6R, PDGFRB, PDGFRA, CALCA, C5AR1, ADRB2, RASGRP1, CCNB1, STAP1, ECT2, TGFB2, TGFB1, CAV2, CAV1, INHBA, GH1, IL6, BMP2, GHR, GRM5, PLAUR, AXIN2, MMP9, GREM1, PSRC1, IFNG, CHI3L1, PDE5A, LTF, THBS1, SNCA, EGF, MAPK14, CD4, LTBR, TEK]
GO:0010886;positive regulation of cholesterol storage;7.0;1.0;0.8509193652572005;9.628524252492122;69.4460343959197;7.8311634786251565;0.002324296273858149;0.7514054297404357;[MSR1, CD36]
GO:0030593;neutrophil chemotaxis;9.0;1.0;0.896240625180289;9.628524252492122;130.2972973825895;5.382624473008031;0.004360933283440787;0.671508291047556;[CXCL6, CCL13, CXCL9, IL1RN, CSF3R, C5AR1, ITGB2, PIK3CD, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, LGALS3, CCL8, CXCR1, CCL7, CCL5, CXCR2, CCL4, PDE4B, CCL2, S100A12, CCL1, NCKAP1L, CCL19, CCL18, CCL23, TGFB2, CXADR, FCER1G, SYK, CCL21, CCL20, PPBP, VAV1, CXCL10, CXCL11, IL1B, XCL2, XCL1, S100A8, PF4]
GO:0050900;leukocyte migration;5.0;0.6023560406934092;0.5914190322076249;8.01908634005802;26.939797568556347;3.896540641279769;9.016507803758389E-4;0.4895102814636384;[IL1RN, CSF3R, PROS1, SIRPG, CXCL13, F11R, CXCL16, VPREB3, EPS8, LGALS3, VPREB1, EDNRB, C3AR1, TNFSF11, SIRPA, IL6R, SLC16A3, CD177, CXADR, ATP1B2, MIF, ATP1B1, CH25H, DOK2, PRTN3, ADAM8, S100A8, GYPA, CALCA, SDC2, C5AR1, FPR1, FPR3, FPR2, TNFRSF11A, GATA3, CORO1A, NUP85, INPP5D, IGLV1-44, S100A12, NCKAP1L, PLCG1, IGHA1, ELANE, NKX2-3, LYN, CCR1, TGFB2, TGFB1, GPR15, CAV1, FN1, TNFRSF10B, AZU1, DEFA1, PPBP, GP6, SELE, COL1A1, SELP, CXCL10, CXCL11, IL6, COL1A2, SELL, SDC1, IGKV3-20, IGHM, CXCL6, CXCL9, ITGAM, ITGB3, ITGB2, PIK3CD, CXCL1, SLC7A11, CXCL3, ITGAL, CXCL2, TREM1, CXCL5, PDE4B, ITGAX, OLR1, FFAR2, CCR7, ITGB7, CCR6, CCR5, CD34, CCR2, IL10, ANXA1, FCER1G, SYK, ITGA4, MMP1, MMP9, VAV1, SLC7A5, ZAP70, HCK, CEACAM1, SLC7A7, SLC7A8, CEACAM6, LCK, SLC7A9, IL1B, CEACAM5, KIT, PECAM1, XCL2, XCL1, CEACAM8, CX3CR1, CCL13, CXCR5, CXCR4, CCL8, IGKC, CXCR1, CCL7, EPCAM, CCL5, CXCR3, TBX21, CXCR2, CCL4, CCL2, CCL1, FYN, CD58, CCL19, CCL18, JAM2, JAM3, CD74, CCL23, CCL21, CCL20, CD2, NLRP12, PTPN6, TEK, CD244, PF4]
GO:0035249;synaptic transmission, glutamatergic;8.0;1.0;0.875;9.628524252492122;25.73829654599903;6.444869117505266;8.61437622431563E-4;0.7045909063862833;[NAPA, P2RX1, GRIK3, SLC17A6]
GO:0043306;positive regulation of mast cell degranulation;11.0;0.8933024483968273;0.8790801765280758;9.584072489921288;1034.300036297698;7.212124270218933;0.03461709140528456;0.8012573229067359;[FGR, FCER1G, SYK, GAB2]
GO:0055096;low-density lipoprotein particle mediated signaling;6.0;1.0;0.8231203125901445;9.628524252492122;23.86341744358871;8.67846133901236;7.986871061555342E-4;0.7669372290569613;[CD36]
GO:0038110;interleukin-2-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;7.379178354882098;0.00101047745553359;0.728290889492758;[SYK, IL2RB, IL2RG, JAK3]
GO:0030194;positive regulation of blood coagulation;8.0;0.7671156992804218;0.7585578496402109;9.34084218004034;205.4468638594546;6.518977089658987;0.006876121643202558;0.7083807915285978;[F2R, SERPINE1, THBS1, F3, SELP, THBD, PDPN, CD36, HPSE, TLR4]
GO:0002281;macrophage activation involved in immune response;6.0;0.9326813400603323;0.7894609826203107;9.541512875502493;81.79914540449643;7.379178354882098;0.0027377437822370863;0.7004918368257019;[CX3CR1, IL33, SUCNR1, TYROBP, SYK, PRKCE, HAVCR2]
GO:0045963;negative regulation of dopamine metabolic process;8.0;0.9326813400603323;0.8413406700301662;9.574457031221845;288.50442548003474;8.390779266560578;0.0096559834836909;0.8041048419030481;[ITGAM, ITGB2, SNCA]
GO:0002283;neutrophil activation involved in immune response;7.0;0.9326813400603323;0.8172600352873667;9.548481544818586;82.20461051260416;3.594988720963838;0.002751314334510546;0.5347672556313635;[CDA, CYFIP1, ABCA13, PSMD3, C3AR1, PRSS3, PRKCD, RNASE3, RNASE2, BIN2, PADI2, CFD, FPR1, FPR2, GNS, C3, S100A12, NCKAP1L, ELANE, JUP, FUCA1, AZU1, LYZ, TCN1, ARHGAP9, SIGLEC9, SERPINA1, PYGL, TIMP2, OLR1, ANXA3, ARG1, NFAM1, PSMA5, PSMA2, SERPINB10, GRN, PTAFR, ALOX5, METTL7A, GSN, LRG1, SLCO4C1, PSMC2, SIGLEC5, ATP8A1, HP, APEH, PYCARD, CLEC5A, LAMP2, CD177, OLFM4, CLEC4D, ADAM8, SLC27A2, S100A8, BRI3, HVCN1, GPR84, PSAP, ATP8B4, DEFA4, DEFA1, NFKB1, PTPRC, LCN2, HPSE, ITGAM, ITGB2, ITGAL, FCAR, ALAD, FCGR3B, GM2A, ITGAX, DSP, CR1, NDUFC2, TNFRSF1B, PECAM1, BPI, ACPP, FGL2, TTR, FCGR2A, P2RX1, IMPDH2, PTPN6, MNDA, FOLR3, LGALS3, ANPEP, SLC11A1, MIF, CHIT1, SLPI, CRISPLD2, STXBP2, MGST1, CD14, PRG2, NBEAL2, PPBP, BST1, VNN1, ORM1, CTSZ, CTSS, GLIPR1, CTSH, CTSG, CD36, SPTAN1, CAMP, CD33, CTSB, CCT2, FCER1G, MME, SYK, RHOG, CEACAM1, CEACAM6, CEACAM8, TLR2, LILRA3, CST3, CXCR1, CXCR2, CD58, CCT8, LILRB2, LILRB3, QPCT, CD68, MPO, PLAU, SIRPA, CD97, CHRNB4, CD93, OSCAR, DOK3, TYROBP, PRTN3, VCL, PSMD14, C5AR1, MGAM, HSPA6, SELL, MS4A3, TNFAIP6, CRISP3, CXCL1, SIRPB1, HK3, PLAUR, MMP8, MMP9, FGR, CHI3L1, LTF, CLEC12A, RETN, MAPK14, S100P, PTX3]
GO:0006520;cellular amino acid metabolic process;6.0;0.406884124246779;0.526562374713534;6.526182243879872;77.81072980309767;4.002522082136061;0.0026042551013992716;0.5278094780068945;[CPOX, MCCC2, KMO, UPB1, MTHFD1, PADI4, GMPS, SLC1A3, GLYAT, ACMSD, ACAT1, AGXT2, SLC6A6, HAL, ALDH6A1, BHMT, P4HA2, NOX4, ALDH18A1, SERINC5, HIBADH, DPYS, PFAS, GHR, HNF4A, HIBCH, ARG1, BHMT2, CAD, PRODH2, SLC7A5, SLC7A7, SLC7A8, DPYD, BCAT1, GART, SLC3A1, SLC25A21, AGMAT]
GO:0051291;protein heterooligomerization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.032160359171186;5.113634533568402;0.00140677858073304;0.5846318204451575;[IKZF1, NUP62, MCCC2, CHRNB4, CLDN3, COL6A2, COL6A1, NUP54, BIRC3, NLGN1, ITPR3, PRKCZ, CTNNA1, CD74, RRM1, JUP, GCH1, COL1A1, COL1A2, P2RX1]
GO:0043304;regulation of mast cell degranulation;10.0;0.7980440201809971;0.8142630219514189;9.523163736834295;224.79395709788088;6.409777797693995;0.007523651442639206;0.7430373465201421;[LYN, FCER1G, SYK, STXBP2, GAB2, FGR, FES, RAC2, HMOX1, IL13RA2]
GO:0050870;positive regulation of T cell activation;8.0;0.6260725219892441;0.688036260994622;8.781226392104918;216.0655637178415;4.493869898942481;0.007231519971253338;0.6048167156182404;[CD86, CD83, TFRC, CD80, SIRPG, IHH, PYCARD, LGALS1, GRAP2, MYB, AKT1, TNFSF11, SIRPA, IL6R, ICOSLG, IL23A, PRKCQ, ADAM8, CARD11, CD274, BLM, HHLA2, GATA3, CD1D, THY1, CORO1A, PRKCZ, RASGRP1, DPP4, KLRK1, BTLA, NLRP3, NCKAP1L, ICOS, LYN, TGFB1, EGR3, VCAM1, TNFSF14, CAV1, IL6, VNN1, PTPRC, BCL6, CD28, CD27, CD24, IL7R, CD3E, SIRPB1, TNFSF13B, DUSP10, CTLA4, CCR7, JAK3, CCR2, HLA-DPA1, HAVCR2, ANXA1, SYK, IL18, PDCD1LG2, VAV1, ZAP70, IFNG, LCK, IL1B, RARA, XCL1, NOD2, HSPD1, PAK1, HLA-DMB, HLX, CCL5, CCL2, FYN, CSK, CCL19, IL12RB1, CD74, CCL21, LILRB1, LILRB2, CD4, CD40LG, CD6, CD5, DNAJA3, HLA-DPB1, PTPN6]
GO:0032928;regulation of superoxide anion generation;7.0;0.8933024483968273;0.7975705894556142;9.405380701177911;29.554879433861746;6.781341354126479;9.891752169867288E-4;0.6977174774718518;[TGFB1, ITGAM, SYK, PRKCD, ITGB2, FPR2, GNAI2, CD177]
GO:0035879;plasma membrane lactate transport;11.0;0.9326813400603323;0.8987696223598284;9.577230958104572;200.27837104673898;8.67846133901236;0.006703136840102508;0.8762458687964789;[SLC16A3]
GO:2001243;negative regulation of intrinsic apoptotic signaling pathway;9.0;0.7436939687323844;0.7680876095464813;9.413412872875176;597.3701724921605;5.233778845410465;0.0199934420750612;0.663896318730187;[LRRK2, CLU, AKT1, PLAUR, MIF, MMP9, SIRT1, SFRP2, NDUFS3, BCL2A1, TAF9, PTGS2, FIGNL1, CD74, WFS1, SOD2, VNN1, CXCL12, BCL2, SNAI2, GRINA, BCL2L1]
GO:0032481;positive regulation of type I interferon production;6.0;0.811012628672052;0.7286266269261705;9.260799472366804;65.23665507211369;5.618190544320798;0.002183412136085803;0.610434838299289;[HMGB2, PTPN22, IFIH1, DHX58, CHUK, SYK, DDX58, MMP12, IRF7, TLR8, TLR7, TLR4, TLR2, HSPD1, CD14, NFKB1, NFKB2, MYD88]
GO:0002292;T cell differentiation involved in immune response;7.0;0.7586651285174919;0.7302519295159464;9.260799472366804;150.83672260445746;6.686031174322154;0.00504836936133411;0.692843310444282;[EOMES, FCER1G, LEF1, RORA, GATA3, CLEC4D, BCL3, IL18R1]
GO:0043552;positive regulation of phosphatidylinositol 3-kinase activity;11.0;0.9326813400603323;0.8987696223598284;9.597752593825367;732.6859750532908;6.375876246018314;0.024522340210466318;0.7584915600596062;[LYN, PDGFRB, PDGFRA, TGFB1, CCL21, FPR2, NOD2, PTK2, FGR, KIT, CCR7, TEK, CCL19]
GO:0043312;neutrophil degranulation;9.0;1.0;0.896240625180289;9.628524252492122;132.80263134205524;3.603287523778533;0.004444784556409926;0.5805129167163294;[CDA, CYFIP1, ABCA13, PSMD3, C3AR1, PRSS3, PRKCD, RNASE3, RNASE2, BIN2, PADI2, CFD, FPR1, FPR2, GNS, C3, S100A12, NCKAP1L, ELANE, JUP, FUCA1, AZU1, LYZ, TCN1, ARHGAP9, SIGLEC9, SERPINA1, PYGL, TIMP2, OLR1, ANXA3, ARG1, NFAM1, PSMA5, PSMA2, SERPINB10, GRN, PTAFR, ALOX5, METTL7A, GSN, LRG1, SLCO4C1, PSMC2, SIGLEC5, ATP8A1, HP, APEH, PYCARD, CLEC5A, LAMP2, CD177, OLFM4, CLEC4D, ADAM8, SLC27A2, S100A8, BRI3, HVCN1, GPR84, PSAP, ATP8B4, DEFA4, DEFA1, NFKB1, PTPRC, LCN2, HPSE, ITGAM, ITGB2, ITGAL, FCAR, ALAD, FCGR3B, GM2A, ITGAX, DSP, CR1, NDUFC2, TNFRSF1B, PECAM1, BPI, ACPP, FGL2, TTR, FCGR2A, P2RX1, IMPDH2, PTPN6, MNDA, FOLR3, LGALS3, ANPEP, SLC11A1, MIF, CHIT1, SLPI, CRISPLD2, STXBP2, MGST1, CD14, PRG2, NBEAL2, PPBP, BST1, VNN1, ORM1, CTSZ, CTSS, GLIPR1, CTSH, CTSG, CD36, SPTAN1, CAMP, CD33, CTSB, CCT2, FCER1G, MME, RHOG, CEACAM1, CEACAM6, CEACAM8, TLR2, LILRA3, CST3, CXCR1, CXCR2, CD58, CCT8, LILRB2, LILRB3, QPCT, CD68, MPO, PLAU, SIRPA, CD97, CHRNB4, CD93, OSCAR, DOK3, TYROBP, PRTN3, VCL, PSMD14, C5AR1, MGAM, HSPA6, SELL, MS4A3, TNFAIP6, CRISP3, CXCL1, SIRPB1, HK3, PLAUR, MMP8, MMP9, FGR, CHI3L1, LTF, CLEC12A, RETN, MAPK14, S100P, PTX3]
GO:1900227;positive regulation of NLRP3 inflammasome complex assembly;7.0;1.0;0.8509193652572005;9.628524252492122;140.3817219977405;7.9853141584524145;0.004698449899916962;0.7592887026755414;[CD36, TLR6, TLR4]
GO:0043313;regulation of neutrophil degranulation;10.0;0.8933024483968273;0.861892236059334;9.537552474286395;150.84516981286367;7.8311634786251565;0.005048652081797471;0.8157270763441555;[ITGAM, SYK, PTAFR, ITGB2, CD177]
GO:0048208;COPII vesicle coating;6.0;1.0;0.8231203125901445;9.628524252492122;62.43707956725794;5.6339389012889365;0.0020897128633926582;0.6112402100070131;[NAPA, SERPINA1, CTSZ, TGFA, F5]
GO:0043315;positive regulation of neutrophil degranulation;11.0;1.0;0.9324289523296623;9.628524252492122;798.7725987099202;8.390779266560578;0.0267342000301538;0.8615337942327104;[ITGAM, PTAFR, ITGB2, CD177]
GO:0006888;ER to Golgi vesicle-mediated transport;6.0;1.0;0.8231203125901445;9.628524252492122;49.13394272044514;4.493869898942481;0.001644468845175705;0.5529370282083849;[, PROS1, NRBP1, COPB2, TGFA, SPTA1, SERPINA1, CTSZ, SPTAN1, TMED6, F5, RAB33B, NAPA, GOPC]
GO:0042590;antigen processing and presentation of exogenous peptide antigen via MHC class I;5.0;0.8933024483968273;0.736892236059334;9.377209824211215;32.556158890958;6.409777797693995;0.0010896253394395913;0.618037346520142;[ITGB5, IFI30, CD36, FCGR1B, FCER1G, CHUK]
GO:0071447;cellular response to hydroperoxide;5.0;0.8653626801206646;0.7229223519212526;9.485423408851448;143.11325921270426;7.697632086000634;0.004789871992277907;0.6838982747154925;[DAPK1, PRKCD, MGST1, CD36]
GO:0030299;intestinal cholesterol absorption;8.0;1.0;0.875;9.628524252492122;82.41160815185232;7.57984905034425;0.002758242359210401;0.7626338329336335;[CD36]
GO:0050766;positive regulation of phagocytosis;8.0;0.7671156992804218;0.7585578496402109;9.34084218004034;175.32691305650852;5.825829909099042;0.005868033996023792;0.6729332124801218;[SIRPG, TNF, SIRPB1, C2, PYCARD, C3, STAP1, CCL2, SIRPA, NCKAP1L, CD36, FCER1G, SLC11A1, AZU1, DNM2, IL1B, PTX3, FCGR2B]
GO:0006090;pyruvate metabolic process;7.0;0.6240278086381567;0.6629332695762788;8.193439727202799;50.36460696881723;5.557565922504363;0.001685658070042802;0.6351335449873193;[HK3, SLC16A3, BPGM, NR4A3]
GO:0072659;protein localization to plasma membrane;6.0;0.7866048967936545;0.7164227609869718;9.260799472366804;65.42666064804821;4.677207199856271;0.002189771451718415;0.5623129063031725;[PLEKHF1, F11R, TNF, CDH1, FCER1G, GOLPH3L, TTC7B, ATP1B1, PKP3, TSPAN33, PRKCZ, EPB41L3, FLNA, TSPAN5, JUP, TSPAN15, EHD3, RAMP1]
GO:0050764;regulation of phagocytosis;7.0;0.6873818243518346;0.6946102774331178;9.05316010758856;47.10255867462412;5.4730085344763;0.0015764802492890249;0.6308092762312435;[SIRPG, TNF, SIRPB1, PYCARD, SIRPA, CD36, FCER1G, SYK, SLC11A1, DNM2, FGR, HCK, IL1B, PRTN3, TLR2, C2, C3, STAP1, CCL2, NCKAP1L, CSK, TGFB1, AZU1, PTX3, FCGR2B]
GO:0044539;long-chain fatty acid import;11.0;1.0;0.9324289523296623;9.628524252492122;75.02792930111643;7.474488534686424;0.0025111172729558144;0.8146746435927894;[ACSL1, CD36, SLC27A2]
GO:0014003;oligodendrocyte development;5.0;1.0;0.7902410118609202;9.628524252492122;34.09911675737102;6.558197802812269;0.001141266750656509;0.6256275524841266;[LYN, EIF2B3, TGFB1, GSN, CD9, WASF3]
GO:0019934;cGMP-mediated signaling;8.0;0.9326813400603323;0.8413406700301662;9.523163736834295;28.507808342730176;7.069023426578259;9.541306898693577E-4;0.7365101867784198;[EDNRB, PRKAR1B, PRKAR2B, CD36]
GO:0060100;positive regulation of phagocytosis, engulfment;9.0;0.9326813400603323;0.8625812952104552;9.577230958104572;308.80984280932773;7.57984905034425;0.010335587528013168;0.7838744581139225;[STAP1, NCKAP1L, CD36]
GO:1903980;positive regulation of microglial cell activation;8.0;1.0;0.875;9.628524252492122;155.50143499853152;7.697632086000634;0.005204493087195169;0.7686572628545723;[ITGAM, LRRK2, ITGB2, STAP1]
GO:0043200;response to amino acid;5.0;0.6441938053840475;0.612337914552944;8.412128928167629;56.712201515420396;5.104244793218563;0.0018981063470534028;0.5512723279577749;[TNF, CTGF, ALAD, SESN3, PDGFRA, EDN1, CHUK, ARG1, MMP2, COL4A1, COL6A1, RRAGD, NAIP, CEBPB, PCNA, ABCB4, PDGFD, PDGFC, FYN, LYN, COL1A1, COL3A1, COL1A2, COL5A2, BCL2L1]
GO:0045742;positive regulation of epidermal growth factor receptor signaling pathway;8.0;0.8259837884571596;0.7879918942285797;9.417215158824915;233.1839134473908;6.280566066213989;0.0078044557311868065;0.6961884407023742;[EGF, PLAUR, TGFA, FASLG, ARAP1, MMP9, EREG, NUP62, AKT1]
GO:0043687;post-translational protein modification;7.0;0.6467165523344657;0.6742776414244334;8.507933057105237;151.15475272427284;3.8799197600437285;0.005059013543235805;0.5493386422205575;[LGALS1, PSMD3, SKP2, ESCO2, MXRA8, SPARCL1, SDC2, C3, FN1, TF, SERPINA1, TIMP1, F5, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2, FAM20C, FSTL1, CST3, SPP1, PSMC6, PSMC2, NUCB1, TNC, MEN1, IGFBP5, CISH, APLP2, IGFBP3, FBXW2, PSMD14, CUL5, SOCS2, IGFBP7, NAE1, WFS1, IL6, COPS5, CCDC22, UBE2M, FBN1, LAMC1, CYR61, VCAN, DTL, LAMB1]
GO:0060907;positive regulation of macrophage cytokine production;9.0;1.0;0.896240625180289;9.628524252492122;311.82526325162985;7.9853141584524145;0.010436510936514811;0.8046099625986299;[CD74, CD36]
GO:0097028;dendritic cell differentiation;5.0;0.811012628672052;0.6957473261969462;9.117698628726131;22.452520143917486;6.343086423195323;7.514656432606705E-4;0.6146267465268138;[LYN, TGFB1, SPI1, TREM2, LILRB1, GATA1, CAMK4, PRTN3, CCR7, LTBR, CCL19]
GO:0050777;negative regulation of immune response;5.0;0.5193749703860713;0.549928497053956;7.293149336675085;78.83017544275083;4.909539177224887;0.0026383750295169523;0.5413150737011212;[IFNA2, TNFAIP3, TNF, LGALS3, DUSP10, DHX58, CTLA4, IL13RA2, JAK3, CCR2, HAVCR2, IL10, CD96, CR1, ANXA1, ARG1, SERPINB9, IRAK3, MMP12, ADCYAP1, CEACAM1, XCL1, SERPING1, CLEC12B, NLRC3, HLX, INPP5D, TBX21, HMOX1, A2M, LYN, IL33, TGFB2, TGFB1, NR1H2, LILRB1, COL3A1, PTPRC, BCL6, PTPN6, FCGR2B, IL7R]
GO:2001268;negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway;13.0;1.0;0.9625549647676366;9.628524252492122;1177.790893893302;8.16763571524637;0.039419601275621635;0.8802482350792397;[PLAUR, MMP9]
GO:0050776;regulation of immune response;4.0;0.37937792944451876;0.4396889647222594;5.635843344046521;22.446924158408432;2.846578861728843;7.512783506617425E-4;0.39557417536826767;[, CYFIP1, TFRC, CLEC10A, SLA2, MYB, TRBC1, C3AR1, UBASH3A, PRKACB, MED1, MEF2C, CXADR, PRKCH, PRKCE, PRKCD, SERPING1, PRKCQ, CFB, CFD, CFH, HHLA2, CFI, FPR1, FPR3, FPR2, GATA3, THY1, PRKCZ, C2, C3, KLRK1, C7, HMOX1, NCKAP1L, S100A14, PLCG1, IGHA1, HLA-DQA2, HLA-DQA1, ELANE, LYN, JUN, HLA-DRB4, FZD5, KIR2DS1, KIR2DS2, COL1A1, COL1A2, HLA-DRB1, DENND1B, ITK, SIGLEC9, IFIH1, CTLA4, JAK3, HLA-DPA1, HAVCR2, ANXA1, ARG1, IFNGR1, FCRL3, NFAM1, IFNGR2, PAWR, SERPINB9, PAX5, FOS, SIRT1, MMP12, FCER2, PLSCR1, RARA, TLR10, HLA-DQB1, PTAFR, UNG, HLA-DMB, CCL19, IL12RB1, NR1H2, CARD9, NR1H4, KIR3DL1, COL3A1, HLA-DPB1, PKN1, CLC, LGR4, PROS1, CXCL13, TNF, CLU, PYCARD, IGHG1, FCGRT, GRAP2, IL13RA2, CD177, LAG3, CD180, MSH6, ADCYAP1, CLEC4D, MSH2, ADAM8, S100A8, BLK, CD274, LY96, CLEC7A, IGLV1-44, MAP2K6, EIF2B3, BMX, NFKB1, PTPRC, BCL6, BCL2, HLA-DRA, LAT, MYD88, ITGAM, ITGB2, PIK3CD, TREM2, PTPN22, ITGAL, TREM1, TNFSF13B, FCGR3A, DUSP10, ITGB7, CR2, CR1, CHUK, ITGA4, PVRIG, LCK, XCL1, LCP2, BIRC3, C1S, UNC93B1, C1R, NLRC3, NLRC4, NOD2, CCL5, FYN, CSK, FCGR1B, FCGR2A, PTPN6, MNDA, CD247, FCGR2B, CLEC2D, ICAM2, ICAM3, LGALS3, DHX58, ICOSLG, RSAD2, SLC11A1, MIF, EREG, IL23A, BTK, TXK, STXBP2, CD1E, CD1D, CD1C, CD1B, CD1A, CD79B, CD79A, CD19, INPP5D, SLAMF7, CD14, A2M, PAG1, SH2D1A, TNFSF13, PILRA, PTK2, MARCO, CD28, CD24, CD200, IGHM, ECM1, CD40, IFNA2, CD3G, CD3E, CD3D, CTSS, RAC2, FCER1A, CTSH, MUC13, CD38, FFAR2, CTSG, CCR7, MUC15, CD36, CD34, CD33, CCR2, IL10, FCER1G, SYK, IL18, GAB2, PARP9, LIME1, VAV1, LAT2, TLR1, NCR1, HCK, CEACAM1, IL1B, KIT, IGHD, TLR8, TLR7, TLR6, TLR5, TLR4, TLR2, C1QB, C1QA, PAK1, IGKC, NPDC1, CD74, IL33, LILRB1, LILRB2, MLH1, CD40LG, C1QC, CD86, CD80, TRAC, IL18RAP, IL6R, CD96, THEMIS, MUC3B, OSCAR, TYROBP, CD8B, CD8A, KLRF1, CD300C, CARD11, KLRB1, C5AR1, KIR2DL1, KIR2DL2, CACNA1F, DDX60, KIR2DL3, RASGRP1, KIR2DL4, STAP1, NLRP3, KLRC1, BTNL8, TGFB2, TGFB1, VCAM1, CAV1, CRTAM, NFKBIA, IL6, NR4A3, SELL, FES, KLRD1, IL7R, IGKV3-20, HMGB2, TNFAIP3, PDE4B, DDX58, MMP2, IRAK3, FGR, ZAP70, IFNG, LTA, IRF7, LTF, COLEC12, CLEC12B, SAMHD1, HSPD1, CNR1, HLX, TBX21, TRAT1, MAPK14, CD4]
GO:0140052;cellular response to oxidised low-density lipoprotein particle stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;56.74958382123113;8.16763571524637;0.0018993574991869968;0.7408135829017477;[CD36, TLR6, TLR4, MYD88]
GO:0007169;transmembrane receptor protein tyrosine kinase signaling pathway;7.0;0.579397892394798;0.6406183114545996;7.564831067780425;28.111912685638995;3.5644675319289507;9.408804185094754E-4;0.533206400604739;[CYFIP1, SLA2, EPS8, STMN1, AKT1, EPHB2, EPHB1, EREG, BTC, BTK, EPHA3, EPHA2, SDC2, SH2D2A, TXK, TGFA, PDGFA, SLC30A10, PRKCZ, FLRT2, PDGFD, PDGFC, NCKAP1L, PLCG1, PAG1, LYN, PILRA, PTK2, COL1A1, NRP1, ITK, PTPRR, NRP2, CD3E, SYK, GAB1, GAB2, VAV1, HCK, KIT, PLCB1, HBEGF, PAK1, NTF3, SORT1, SORBS1, SULF1, SULF2, NCF2, NCF4, CTGF, FGF5, EFEMP1, GRAP2, AP2M1, PDGFRB, PDGFRA, MATK, TSC2, PDGFRL, DOK2, COL4A2, CD8B, KIF16B, COL4A1, CD8A, BLK, CSF1R, CUL5, RASGRP4, FOXO1, SOCS2, STAP1, TGFB1, CAV2, CRIM1, BMX, VIL1, GH1, NR4A3, FES, CSPG4, ITGB3, GHR, BLNK, MMP2, MMP9, FGR, ZAP70, LCK, ESRP1, LCP2, REPS2, POLR2E, FYN, CSK, POLR2I, POLR2J, POLR2K, POLR2L, TRAT1, EGF, MAPK14, CD4, CD7, TEK]
GO:1901216;positive regulation of neuron death;6.0;0.811012628672052;0.7286266269261705;9.260799472366804;58.38287487682085;5.370354380416217;0.001954022280951067;0.5977604853516485;[ITGAM, CTSZ, ITGB2, FASLG, CLU, MYB, FOS, KMO, CDC34, IL1B, TLR6, TLR4, TP53BP2, FYN, SNCA, EGR1, JUN, TGFB2, EIF2S1, FCGR2B, UBE2M]
GO:1990000;amyloid fibril formation;5.0;1.0;0.7902410118609202;9.628524252492122;65.1103285866179;7.697632086000634;0.0021791841023027143;0.6838982747154925;[GSN, CD36]
GO:0050663;cytokine secretion;9.0;0.6056485694559711;0.6990649099082746;8.227631091951078;133.331941423656;5.9928839937622085;0.004462500088492957;0.7027169913188946;[NLRC4, GATA3, NOD2, NLRP3, S100A12, CCR7, ITGB6, CD36, CCL19, LYN, ABCA1, NR1H4, LILRB1, CHI3L1, LCP2, TLR6, TLR4, CARD11, TLR2]
GO:0070372;regulation of ERK1 and ERK2 cascade;10.0;0.8653626801206646;0.8479223519212526;9.541512875502493;158.98679164778278;4.069963362931594;0.0053211448376282704;0.623379127513894;[PHB2, TNF, CTGF, PYCARD, TNFSF11, EPHB2, EPHB1, PDGFRB, PDGFRA, F2R, MIF, ADCYAP1, ATF3, EPHA3, EPHA2, CSF1R, C5AR1, PDGFA, FBLN1, FPR2, TNFRSF11A, SLC30A10, PRKCZ, RASGRP1, PKHD1, PDGFD, PDGFC, SLAMF1, LYN, CCR1, JUN, TGFB1, LIF, FN1, MARCO, BMP2, NOX4, NRP1, PTPRR, TREM2, PTPN22, CYR61, DUSP10, TIMP3, CCR7, EMILIN1, CD36, HAVCR2, SYK, DUSP1, DUSP6, CEACAM1, IL1B, KIT, XCL2, CHI3L1, XCL1, TLR4, CCL13, NOD2, GNAI2, CCL8, GPNMB, CCL7, CCL5, CCL4, CCL2, CCL1, CSK, CCL19, CCL18, CD74, CCL23, CCL21, CCL20, TIE1, KLF4, CD4, NLRP12, PTPN6, TEK]
GO:0019370;leukotriene biosynthetic process;8.0;0.8653626801206646;0.8076813400603323;9.488762310116963;324.40599840797483;6.781341354126479;0.010857576820271119;0.7217981122146513;[SYK, ALOX5]
GO:0071222;cellular response to lipopolysaccharide;6.0;1.0;0.8231203125901445;9.628524252492122;237.99812851129587;4.786641040901733;0.007965583176863442;0.5679093580234316;[CD86, CXCL6, CXCL9, CD40, IL1RN, CD80, SERPINE1, HMGB2, TNFAIP3, CXCL1, CXCL13, CXCL3, CXCL2, CXCL5, PYCARD, EDNRB, PDE4B, CTSG, CD36, CCR5, HAVCR2, IL10, GHSR, MEF2C, ARG1, CD180, PDCD1LG2, TNFRSF1B, IL1B, RARA, ADAM9, TLR4, CX3CR1, CD274, CEBPB, CEBPE, KLRK1, STAP1, NLRP3, CCL2, CD14, ABCA1, CCL20, NR1H2, DEFA4, NR1H4, LILRB1, DEFA1, LILRB2, PPBP, MAPK14, NFKB1, CXCL10, CXCL11, IL6, PF4]
GO:0071223;cellular response to lipoteichoic acid;6.0;1.0;0.8231203125901445;9.628524252492122;155.87545856417063;7.474488534686424;0.005217011319337755;0.7053660038532718;[CCL20, TREM2, CD36, CD14, MAPK14, TLR2]
GO:0045087;innate immune response;4.0;0.6799073451904818;0.5899536725952409;8.162187183698695;26.470038109745843;3.422703586883119;8.859283540455166E-4;0.42503722060519694;[, CLEC10A, ADARB1, SLA2, HERC5, LGALS3, TRBC1, DHX58, TRIM25, RNASE6, RNASE3, MIF, SLPI, IL23A, BTK, SERPING1, PADI4, TRIM10, NAIP, CFB, CFD, CFH, TXK, CFI, GATA3, CD1D, LY9, C2, C3, KLRK1, C7, SLAMF7, S100A12, CD14, IGHA1, SLAMF1, LYN, KIR2DS1, KIR2DS2, SH2D1A, KIR2DS4, KIR2DS5, PTK2, MARCO, VNN1, IFNA5, IFNA4, IGHM, ITK, IFNA7, IFNA2, IFNA8, IFIH1, JAK3, CAMP, HAVCR2, ANXA1, FCER1G, SYK, ARG1, IL18, PARP9, TLR1, HCK, IGHD, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, TLR2, C1QB, C1QA, LILRA5, IGKC, CARD9, NR1H4, KIR3DL1, LGR4, C1QC, NCF2, CLU, PYCARD, IGHG1, GRAP2, CLEC5A, CD177, IFNA14, IFNA16, CD180, MATK, CLEC4D, TYROBP, S100A8, IFNA10, BLK, CSF1R, LY96, DDX60, CORO1A, CLEC7A, NLRP3, IFNA21, TGFB1, DEFA4, LY86, DEFA1, BMX, NFKB1, NFKB2, FES, LCN2, KLRD1, SERINC5, ITGAM, KIR3DS1, CRISP3, HMGB2, PIK3CD, TREM2, TREM1, SIRPB1, CR2, CR1, CHUK, DDX58, FGR, ZAP70, LCK, IRF7, LTF, COLEC12, C1S, UNC93B1, C1R, HIST1H2BK, NLRC4, NOD2, FYN, CSK, MX2, GZMB, PML, GZMM, CD6, PTX3, PTPN6, CD244]
GO:0070373;negative regulation of ERK1 and ERK2 cascade;11.0;1.0;0.9324289523296623;9.628524252492122;1180.902522994834;5.6339389012889365;0.039523744701365535;0.7205488497465309;[PTPRR, FBLN1, DUSP10, TIMP3, CSK, EMILIN1, EPHB2, LYN, DUSP1, LIF, KLF4, DUSP6, NLRP12, TLR4, ATF3]
GO:0006508;proteolysis;5.0;0.5517781253862416;0.5661300745540411;7.338517941704937;47.85814540089318;2.5985281439167696;0.001601769057033345;0.42312986198474045;[, PSMD3, PRSS3, UQCRC1, PRKCQ, UQCRC2, CFB, CFD, ENPEP, CFI, GATA3, ADAMTS12, C2, C3, ELANE, BARD1, ST14, ACE, HACE1, PLK1, AZU1, TGFB1I1, IFIH1, MMP28, OLR1, ACTL6A, SIRT1, F3, MMP12, PSMA5, PSMA6, PSMA3, PSMA4, PSMA2, MMP19, FAM105A, ADAM28, USP1, USP9Y, F11, PSMC6, PSMC2, APEH, IGHG1, RUVBL1, RNF43, FBXW2, CDC25A, ADAM2, ADAM9, ADAM8, ADAM7, CUL5, AEBP1, TMEM27, IGLV1-44, CLCA4, WFS1, DHCR24, NFKB1, COPS5, CDK1, ADAMTS1, ADAMTS20, ASPH, MEP1A, DTL, BIRC3, C1S, C1R, HM13, FGL2, RNF24, GZMA, GZMB, PML, GZMH, GZMK, GZMM, EIF3F, CDC20, ANPEP, TRIM25, SKP2, CDC34, CFTR, CTSZ, CTSW, BRCA1, PCSK6, CTSS, CTSH, CTSG, CTSB, MME, RNF144B, C1QB, C1QA, CD5L, TMPRSS2, IGKC, PERP, RANBP2, RANBP1, IL33, FAP, NEDD4, MAD2L1, C1QC, IHH, BUB1B, PLAU, PCOLCE, ADAM12, PRTN3, PSMD14, PSEN2, HTRA1, ADRB2, TRHDE, DPP4, CCNB1, NLRP3, TGFB1, UBE2C, ISG15, NFKBIA, IGKV3-20, TNFAIP3, MMP1, DDX58, MMP2, MMP8, MMP9, CCNA2, LTF, AURKB, TBX21, NRIP3, RBMX]
GO:0072672;neutrophil extravasation;9.0;1.0;0.896240625180289;9.628524252492122;63.39800827118407;7.9853141584524145;0.0021218742823333786;0.8046099625986299;[PECAM1, PIK3CD, PRTN3, CD177]
GO:0070374;positive regulation of ERK1 and ERK2 cascade;11.0;0.9326813400603323;0.8987696223598284;9.604993755081928;1178.864923326294;4.330336256014159;0.03945554807418015;0.6538825498434562;[PHB2, TNF, CTGF, PYCARD, TNFSF11, EPHB2, EPHB1, PDGFRB, PDGFRA, F2R, MIF, ADCYAP1, EPHA3, EPHA2, CSF1R, C5AR1, PDGFA, FPR2, TNFRSF11A, SLC30A10, PRKCZ, RASGRP1, PDGFD, PDGFC, SLAMF1, CCR1, JUN, TGFB1, MARCO, BMP2, NOX4, NRP1, TREM2, PTPN22, CCR7, CD36, HAVCR2, IL1B, KIT, XCL2, CHI3L1, XCL1, CCL13, NOD2, GNAI2, CCL8, GPNMB, CCL7, CCL5, CCL4, CCL2, CCL1, CCL19, CCL18, CD74, CCL23, CCL21, CCL20, TIE1, CD4, TEK]
GO:0071226;cellular response to molecule of fungal origin;5.0;1.0;0.7902410118609202;9.628524252492122;58.24779613319063;9.083926447120524;0.00194950131696474;0.7547934328124444;[SYK, BTK]
GO:0035722;interleukin-12-mediated signaling pathway;7.0;1.0;0.8509193652572005;9.628524252492122;30.19135422731818;5.948432231191374;0.00101047745553359;0.6551224661907153;[STAT4, IL12RB1, IL12RB2, IL10, SERPINB2, MIF, SOD2, IFNG, LCP1, PLCB1]
GO:0042531;positive regulation of tyrosine phosphorylation of STAT protein;11.0;1.0;0.9324289523296623;9.628524252492122;1230.2749798860389;5.618190544320798;0.04117619640118775;0.7197434780388068;[CSF1R, CD40, IFNA2, GHR, CCL5, FYN, IL6R, LYN, LIF, IL18, PARP9, GH1, IL6, IFNG, IL23A, KIT]
GO:0003056;regulation of vascular smooth muscle contraction;8.0;0.8259837884571596;0.7879918942285797;9.533214072687796;76.73452313494074;7.697632086000634;0.0025682354327391786;0.7686572628545723;[DOCK5, DOCK4, CHRM1, P2RX1]
GO:0002762;negative regulation of myeloid leukocyte differentiation;8.0;0.7671156992804218;0.7585578496402109;9.352270875863963;700.1468303315412;5.948432231191374;0.02343328431995837;0.6792031009335148;[INPP5D, HOXA7, LYN, LILRB1, INHBA, LILRB3, NME1, CEACAM1, RARA, TRIB1, TLR4, LTF, FBN1, C1QC]
GO:0006687;glycosphingolipid metabolic process;7.0;0.6763753087927167;0.6891070196535589;9.040737587590003;147.45961877692685;5.734022359845919;0.004935340735422783;0.64415753539903;[GAL3ST1, GBA3, GM2A, PSAP, ITGB8, KIT]
GO:0002755;MyD88-dependent toll-like receptor signaling pathway;12.0;0.8933024483968273;0.8947715367885583;9.5544162803384;412.6549923027037;6.280566066213989;0.013811191226989502;0.7693087532925187;[LY96, HSPD1, CD36, CD14, IRAK3, TLR1, BTK, TLR8, TLR10, TLR7, TLR6, TLR5, TLR4, MYD88, TLR2]
GO:0050715;positive regulation of cytokine secretion;9.0;0.6913464685778243;0.7419138594692012;9.0689084645567;549.4808578036607;5.03214149931722;0.0183906298100222;0.6535845754738829;[ORM1, LRRK2, PTPN22, TNF, PYCARD, IFIH1, CLEC5A, FFAR2, CD34, HAVCR2, IL10, POSTN, CHUK, SYK, DDX58, F2R, MIF, IL17RB, MMP12, TLR1, FGR, IL1A, IL1B, IGHD, TLR8, TLR4, TLR2, CD274, CSF1R, TWIST1, GATA3, NOD2, PRKCZ, RASGRP1, NLRP3, CD58, CCL19, CD14, IL33, FZD5, CRTAM, MAPK14, CD2, NLRP12, CD244, IL17A]
GO:0019886;antigen processing and presentation of exogenous peptide antigen via MHC class II;5.0;1.0;0.7902410118609202;9.628524252492122;42.20009821028515;5.192106149009898;0.0014123993094755708;0.5557655617789146;[KIF11, IFI30, CTSS, HLA-DOA, HLA-DOB, AP2M1, HLA-DPA1, LAG3, FCER1G, DNM2, KIF2C, HLA-DQB1, HLA-DMA, HLA-DMB, RACGAP1, HLA-DQA2, HLA-DQA1, CD74, HLA-DRB4, CENPE, KIF18A, KIF26A, HLA-DPB1, HLA-DRA, FCGR2B, HLA-DRB1]
GO:0070447;positive regulation of oligodendrocyte progenitor proliferation;9.0;1.0;0.896240625180289;9.628524252492122;486.0421787932986;8.67846133901236;0.016267394314649825;0.8400575416471059;[LYN, LRP2]
GO:0035556;intracellular signal transduction;5.0;0.5140152493238541;0.5472486365228473;6.9204740513899115;23.17027026302992;2.4005655013542495;7.75488093814194E-4;0.41300604323788886;[AKT1, MEF2A, MEF2C, PRKAR1B, AGTR1, FPR1, PDGFA, FPR2, GATA3, IQGAP3, PRKAR2B, SFN, LYN, ABCA1, JUN, HACE1, AZU1, COL1A2, ARHGAP6, ARHGAP4, JAK3, DUSP1, GMIP, SIRT1, DUSP6, PTAFR, STAT4, DMD, PKN1, LGR4, CTGF, SESN3, KCNH1, KCNH2, CISH, MSH6, ADCYAP1, MSH2, BLK, LY96, SOCS2, TNFRSF10B, BMX, CORO2A, NFKB1, NFKB2, LRRK2, PIK3CD, TNFRSF1B, LCP2, LCP1, DTL, BIRC3, PPP1R15A, IL2RG, CCL5, E2F1, CCL2, E2F2, FYN, E2F7, SH2B1, IL2RB, PTPN6, TNFSF11, PAQR3, MIF, EREG, BTC, BTK, TRIB1, RIN2, EPHA2, RACGAP1, CD14, PAG1, CCR1, PTK2, CALM3, RGL4, CD24, RGL1, CD40, CETN3, BRCA1, BRCA2, CCR9, RAC2, CTSH, CCR7, CCR6, CD36, CCR5, SPTAN1, CCR2, IL18, GAB2, LAT2, MC3R, IL1B, KIT, DEPDC1, YAP1, PCNA, GNAI2, PAK1, PERP, KITLG, FKBP1B, RAMP1, CD80, CELSR1, CCRL2, PDGFRB, PDGFRA, DOK2, DOK3, TYROBP, CARD11, CALCA, PSEN2, RASGRP1, RASGRP4, SPTA1, CCNB1, ECT2, VCAM1, GH1, GNAQ, TNFAIP3, GHR, GRM5, ARHGEF12, DDX58, IRAK3, CCNA2, NDUFS4, IRF7, SHANK3, BCL2A1, EPS8L1, EPS8L3, EGF, MAPK14, MAPK13, TEK, CYFIP1, EPS8, STMN1, CYP1B1, MED1, PRKCH, DAPK1, PRKCE, PRKCD, DEPDC1B, ADCY9, LGALS12, PRKCQ, PRKCZ, HMOX1, PLEK2, PLCG1, PLK2, PLK1, ITK, CDKN1A, BTG2, ADM, IFIH1, NFAM1, PAX2, CIT, PLCB1, HBEGF, GSN, CCL20, CARD9, POU4F1, IL5RA, TNF, SLC8A1, FGF5, PYCARD, GRAP2, STK32B, MEN1, LHCGR, MAP2K2, IGFBP5, DGKZ, NRBP1, RAB32, MELK, CSF1R, CALCRL, CUL5, ITPR3, MAP2K6, DHCR24, BCL6, CNOT3, BCL3, CDK1, BCL2, CSPG4, LAT, BCL2L1, TREM1, CHUK, TFDP1, IL3RA, CX3CR1, CEBPB, NLRC3, NOD2, RAB21, PLN, PML, DNAJA3, CALML4, EDNRB, PPP2R1A, CHEK1, RPS6KA1, SOX4, PTGDR, TIAM2, SIK1, INPP5D, TP53BP2, CCR10, PRL, RALGPS2, MAP4K1, EDN1, STRADB, RHOG, RHOH, AVPR1A, GFRA3, VAV1, RAB33B, TLR8, TLR7, RHOU, SGK1, TLR4, GUCY2C, PTGER2, CXCR5, CXCR4, CXCR6, CXCR1, CXCR3, CXCR2, PDPN, MLH1, CAMK4, CAMK1, SIPA1, SIRPG, ARHGDIA, ARHGDIB, TSC2, ATP1B1, CSF2RB, ADRB2, CSF2RA, TGFB1, SELE, NFKBIA, SELP, ARHGAP30, JMY, DOCK5, DOCK4, MCTP1, CXCL1, TMEM100, BLNK, PTGIR, TGFBR3, ZAP70, CAMK2D, NCAM1, TSHR]
GO:0050830;defense response to Gram-positive bacterium;7.0;1.0;0.8509193652572005;9.628524252492122;71.44439831434403;5.334422371190153;0.0023911797157970473;0.6237219733958743;[SEH1L, HIST1H2BK, C5AR1, HMGB2, TNF, KLRK1, NLRP3, CD36, CAMP, HAVCR2, DEFA4, CARD9, RNASE6, RNASE3, DEFA1, LYZ, FGR, IL6, LTA, MYD88, TLR2]
GO:0042308;negative regulation of protein import into nucleus;9.0;0.9326813400603323;0.8625812952104552;9.592156608321247;779.1118030345037;7.138016298065211;0.026076170892464952;0.7612791106150483;[MDFIC, CD36, PKIG]
GO:0002092;positive regulation of receptor internalization;9.0;0.9326813400603323;0.8625812952104552;9.585964638073326;393.55365953464764;6.599019797332524;0.013171886809326083;0.7337148045016781;[GREM1, SFRP4, SYK, EGF, FMR1, NTF3, SELE]
GO:0051260;protein homooligomerization;6.0;0.8933024483968273;0.7697715367885581;9.405380701177911;42.032160359171186;4.056761851073058;0.00140677858073304;0.5305833023127396;[CDA, KCNG2, PRF1, TCL1A, TNFSF11, MIF, OLFM4, CLDN3, KCTD12, KCTD15, BLM, MGST1, ITPR3, ACAT1, CD79B, CD79A, NACC2, HMOX1, ECT2, VASP, CAV1, EHD3, DPYS, CD3G, CD3E, CD3D, ALAD, EMILIN1, TK1, FCER1G, KCND2, VWF, ARG1, NUP54, ACPP, FBP1, COLEC12, NLGN1, HM13, KCNA5, NLRC4, SAMHD1, PLN, GCH1, SOD2, MARCKS, RAD51, P2RX1, IMPDH2, GOPC, CD247, RBMX]
GO:1902961;positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process;11.0;1.0;0.9324289523296623;9.628524252492122;1348.57412674769;7.9853141584524145;0.04513556238432715;0.8407982897480031;[LYN]
GO:0001798;positive regulation of type IIa hypersensitivity;12.0;0.9326813400603323;0.9144609826203107;9.606051396640064;1378.0251110012991;9.083926447120524;0.04612126032313042;0.9126727335416687;[C3, FCER1G]
GO:0050727;regulation of inflammatory response;6.0;0.5272636092234699;0.5867521172018795;7.400047131651798;31.586589572713706;3.8007227183825356;0.00105717472691369;0.517489449159909;[SERPINE1, EDNRB, C3AR1, TNFSF11, IL1R1, IL1R2, PRKCD, IL23A, BTK, AGTR1, SERPING1, CFB, CFH, CFI, GATA3, ADAMTS12, PLA2G7, C2, C3, C7, CD19, S100A12, A2M, ELANE, LYN, BST1, CD28, FFAR2, CCR7, CCR2, IL10, ANXA1, FCER1G, IL18, IL17RB, PSMA6, HCK, IL1B, TLR10, TLR7, TLR6, TLR4, TLR2, C1QB, C1QA, PTGS2, NT5E, IGKC, CCL18, IL33, CCL23, NR1H4, NLRP12, ZYX, IL17A, C1QC, PROS1, RORA, TNF, CLU, ETS1, CDH5, IGHG1, GHSR, ADCYAP1, FANCD2, ADAM8, S100A8, SUCNR1, CALCRL, C5AR1, TNFRSF11A, IGLV1-44, NLRP3, SELE, NFKB1, NFKBIA, IL6, BCL6, IGKV3-20, MYD88, TNFAIP6, TNFAIP3, DUSP10, CR2, CR1, TNFRSF1B, LTA, XCL1, BIRC3, C1S, C1R, NLRC3, NOD2, CNR1, CCL5, CCL4, SNCA, MAPK14, KLF4, MAPK13, CD6, TEK, FCGR2B]
GO:0010942;positive regulation of cell death;5.0;0.5391707831400974;0.559826403430969;7.325939159498076;41.77857356132841;3.304727333179569;0.0013982912588225433;0.45924492136526085;[MYB, AKT1, CYP1B1, HOXA5, MEF2C, DAPK1, PRKCD, ATF3, HMOX1, SFN, PLCG1, BARD1, LYN, JUN, NOX4, NOX1, CDKN1A, ADM, CTLA4, TIMP3, ANXA1, DUSP1, PAWR, FOS, SIRT1, F3, DUSP6, AES, PTGS2, FGD3, FGD4, FRZB, CASP8AP2, GSN, BIK, G0S2, POU4F1, HP, TNF, CLU, CTGF, PYCARD, IGFBP3, F2R, MELK, MAL, ADAM8, S100A8, CD274, FOXO1, NACC2, MAP2K6, TNFRSF10B, BCL6, BCL2, BCL2L1, ITGAM, PLEKHF1, LRRK2, ITGB2, PIK3CD, FASLG, CYR61, ITGA4, TFDP1, LCK, LRP1, NLRC4, CCL5, E2F1, CCL2, FYN, GZMA, GZMB, PML, P2RX1, MNDA, FCGR2B, IFIT2, PPP2R1A, SOX7, SOX4, TIAM2, SFRP4, SFRP2, CDC34, IFI27, SIK1, INPP5D, TP53BP2, EGR1, TNFSF12, ITM2C, TOP2A, CD40, CTSZ, CTSH, CD36, IL10, VAV1, IL1B, TLR6, TLR4, CXCR2, CTNNA1, SORT1, LILRB1, PPP1CA, NLRP12, CD40LG, FAP, DLC1, PDGFRB, KMO, NLRP3, ECT2, TGFB2, TGFB1, VDR, CAV1, INHBA, EIF2S1, IL6, BMP2, NR4A3, JMY, UBE2M, TNFAIP8, YWHAH, ARHGEF12, PLAUR, AXIN2, MMP9, DNM2, IFNG, LTA, CAMK2D, BCL2A1, THBS1, HSPD1, CNR1, SNCA, HSPE1, SOD2, LTBR]
GO:0031623;receptor internalization;7.0;0.7248374789738407;0.7133381047441208;9.201080237665183;64.84818556283533;5.682729065458369;0.0021704104112101165;0.6415343939386686;[ACHE, CALCRL, LRP1, TFRC, ITGB2, ADM, CXCR1, CXCR2, CD36, AP2M1, SNCA, FCER1G, SYK, CAV1, LILRB1, DNM2, CEACAM1, NEDD4, CD9, RAMP1]
GO:0071404;cellular response to low-density lipoprotein particle stimulus;6.0;1.0;0.8231203125901445;9.628524252492122;56.74958382123113;7.004484905440688;0.0018993574991869968;0.6813299963962409;[ABCA1, FCER1G, SYK, ITGB2, CD9, CD36]
GO:0007193;adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway;8.0;0.7866048967936545;0.7683024483968273;9.117698628726131;28.36322711391944;5.334422371190153;9.492916862557204E-4;0.6478026081386739;[CHRM2, GNAZ, GABBR1, EDN1, CHRM1, GPR37, HTR1E, NPY1R, GRIK3, FPR2, GNAI1, GNAI2, AKAP12, MARCO, GRM5, EDNRA, ADCY9, RGS1, HRH4, PSAP, FLNA, S1PR3, DRD4]
GO:0043407;negative regulation of MAP kinase activity;12.0;0.811012628672052;0.8536266269261705;9.539970855150678;2610.1786565788484;5.4730085344763;0.08736033062741366;0.7280102235641875;[PTPN22, DUSP10, PPP2R1A, NUP62, DUSP2, DUSP1, PAQR3, PRKCD, IRAK3, DUSP6, SFRP2, IL1B, LYN, CAV1, PTPN6]
GO:0042310;vasoconstriction;8.0;0.7508913569872202;0.7504456784936101;9.102431156595342;39.67967046252893;6.343086423195323;0.0013280428609958766;0.6993857346658935;[EDN1, CAV1, SLC8A1, ACTA2, EDNRA, EDNRB, P2RX1, CD38]
GO:0050850;positive regulation of calcium-mediated signaling;8.0;0.7763722522362496;0.7631861261181248;9.283683766200392;239.92176968958296;6.039404009397101;0.008029965715936047;0.6838554019015759;[TREM2, CD3E, TNF, JPH2, CCL4, SYK, TRAT1, ZAP70, P2RX5, CD4, CALM3]
GO:0030889;negative regulation of B cell proliferation;9.0;1.0;0.896240625180289;9.628524252492122;506.3396801226706;7.004484905440688;0.016946733417578675;0.7544503089863854;[LYN, IL10, TNFRSF13B, PAWR, INPP5D, BTK, CTLA4, MNDA, PKN1, FCGR2B]
GO:0071310;cellular response to organic substance;4.0;0.44223782556504454;0.47111891278252227;5.954033535830285;41.65973036582596;2.624021992742989;0.0013943136840210083;0.3841926067383783;[CYFIP1, PID1, SPI1, TFRC, SERPINE1, SPINT2, PHB2, MYB, AKT1, HOXA2, CYP1B1, PRKACB, JUNB, MED1, MEF2C, DAPK1, PRKCE, PRKCD, ADCY9, SPINT1, PRKAR1B, PADI2, ABCB4, FPR2, GATA3, SLC30A10, ADAMTS12, IQGAP3, GATA1, EPB41L5, KLRK1, PRKAR2B, PDGFD, PDGFC, ST3GAL6, PLCG1, LYN, ABCA1, JUN, JUP, CDC6, COL1A1, COL1A2, NOX4, SNAI2, EZH2, GABRB1, IFIH1, TIMP3, HLA-DPA1, HAVCR2, ANXA1, DUSP1, ARG1, FOS, SIRT1, PAX2, RARA, GAS1, CCL13, PTAFR, PTGS2, SPP1, CCL19, CCL18, IL12RB1, P2RY13, CCL23, GSN, CCL21, CCL20, NR1H2, NR1H4, POU4F1, COL3A1, ZYX, FOSB, PF4, TNC, RORA, CXCL13, TNF, SLC8A1, PYCARD, SESN3, CDH1, RUVBL2, MEN1, TLE4, LHCGR, DGAT2, IGFBP5, CD180, ADCYAP1, ADAM9, CD274, CSF1R, BLM, CALCRL, FECH, CORO1A, FOXO1, SOCS2, PSAP, IGFBP7, MAP2K6, OSBPL7, DEFA4, DEFA1, NFKB1, CXCL10, CXCL11, SLC26A3, BCL2L1, MCM7, LRRK2, TREM2, PTPN22, ALAD, CHUK, ITGA4, TNFRSF1B, IL3RA, XCL2, XCL1, MCM2, CX3CR1, CEBPB, LRP1, CEBPE, NOD2, P2RY6, CCL8, CCL7, CCL5, CCL4, E2F1, CCL2, CCL1, FYN, CSK, KLF4, PML, KLF1, RAD51, KLF5, IMPDH2, PTPN6, PTPN7, FCGR2B, PTPN4, IL1RN, SPARC, AQP9, IFIT1, IFIT3, AQP1, IFIT2, TCL1A, EDNRB, LGALS1, TNFSF11, TRIM25, SOX4, PTGDR, RUNX2, POR, CDC34, KCNQ1, RRAGD, BTK, SIK1, EPHA3, CFTR, STXBP2, TWIST1, CD14, EGR1, EGR2, EGR3, PPBP, ID1, ROBO2, NRP1, CD40, BRCA1, CTSS, CTSH, FFAR2, CTSG, CCR7, CD36, CCR5, CTSB, MAP4K1, IL10, EDN1, MME, IL18, PDCD1LG2, AVPR1A, NME1, CEACAM1, IL1B, KIT, TLR6, TLR4, TLR2, YAP1, DTYMK, PTGER2, SATB2, CXCR4, GNAI1, PAK1, CTNNA1, CD58, LILRB1, LILRB2, SORBS1, NLRP12, CD68, RAMP1, IL18R1, IL17A, CD86, CD80, PDGFRB, GHSR, PDGFRA, POSTN, PCOLCE, KMO, COL4A2, KIF16B, COL4A1, CALCA, TCF7, CSF2RB, ADRB2, CCNB1, STAP1, NLRP3, GAS2L1, TGFB1, VCAM1, CAV1, HSPA6, INHBA, BSPRY, NR4A2, NFKBIA, VIL1, NR4A1, IL6, BMP2, KIF18A, LIN28A, NR4A3, COL5A2, ALPL, FBN1, CXCL6, CXCL9, HMGB2, TNFAIP3, CXCL1, CXCL3, CXCL2, CXCL5, GHR, TMEM100, GRM5, PDE4B, DDX58, MMP2, GLP2R, CAD, DNM2, CCNA2, COL6A1, CHI3L1, COLEC12, LEF1, THBS1, TBX21, SNCA, MAPK14, TSHR, MAPK13, CD4, RBMX]
GO:1990822;basic amino acid transmembrane transport;10.0;0.7508913569872202;0.7906866903545304;9.277126365654233;267.5048622669104;7.697632086000634;0.008953147001327533;0.8088982747154926;[SLC7A7, SLC3A1]
GO:0050731;positive regulation of peptidyl-tyrosine phosphorylation;10.0;0.7866048967936545;0.8085434602577476;9.446202695698167;779.3603785568229;4.60092389510664;0.02608449049149353;0.6505324738215158;[NRP1, CD40, CD80, ITGB3, IFNA2, TREM2, CD3E, GHR, GRM5, CD36, IL6R, SYK, IL18, MIF, PARP9, EREG, GREM1, IFNG, BANK1, IL23A, KIT, HBEGF, CSF1R, TGFA, GATA1, CCL5, NTF3, STAP1, FYN, LYN, CD74, TGFB1, ACE, EGF, LIF, GH1, CD4, IL6, CSPG4, CD24]
GO:0050853;B cell receptor signaling pathway;10.0;0.9326813400603323;0.8815816818910864;9.582004236857228;219.43154282413207;4.948759890378168;0.007344176262756358;0.6683208227957298;[, BLK, IGHM, ITK, TXK, PIK3CD, CD79B, CD79A, IGHG1, IGKC, CD19, TRBC1, CTLA4, CD38, NCKAP1L, IGHA1, LYN, MEF2C, SYK, BMX, LIME1, LAT2, PTPRC, LCK, BTK, IGHD, BCL2, PTPN6, MNDA]
GO:0038124;toll-like receptor TLR6:TLR2 signaling pathway;12.0;1.0;0.9481203125901445;9.628524252492122;412.6549923027037;8.390779266560578;0.013811191226989502;0.8772251544931927;[CD36, TLR6, CD14, TLR2]
GO:1905572;ganglioside GM1 transport to membrane;8.0;1.0;0.875;9.628524252492122;123.75745464024328;9.777073627680469;0.00414205063233081;0.875;[PSAP]
GO:2000670;positive regulation of dendritic cell apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;128.63842847306384;8.67846133901236;0.004305412433924055;0.8400575416471059;[LYN]
GO:0031295;T cell costimulation;9.0;0.9326813400603323;0.8625812952104552;9.587702257971866;354.8971974647038;5.845247994956144;0.011878089812402261;0.6951668794741764;[CD86, CD274, HHLA2, CD80, CD3E, TNFSF13B, DPP4, PAK1, KLRK1, LGALS1, GRAP2, BTLA, AKT1, CTLA4, FYN, CSK, CCL19, ICOS, ICOSLG, LYN, TNFSF14, CCL21, CAV1, PDCD1LG2, VAV1, CD40LG, LCK, CD5, CD28, PTPN6, CD24, CARD11]
GO:0043410;positive regulation of MAPK cascade;10.0;0.6634067003016617;0.7469443620117512;9.174268980214526;1017.2390743488962;3.4929394666096676;0.03404607636272706;0.5938700986216354;[, IL1RN, PHB2, PROK2, TNFSF11, EPHB2, EPHB1, PRKCE, MIF, EPHA3, EPHA2, FPR1, TGFA, PDGFA, FPR2, SLC30A10, IQGAP3, PRKCZ, PDGFD, PDGFC, S100A12, ELANE, SLAMF1, CCR1, JUN, FZD5, LIF, FZD8, MARCO, NOX4, CD27, CD24, NOX1, EZH2, NRP1, CD40, TIMP2, CCR7, CD36, HAVCR2, MAP4K1, EDN1, GPR37, SYK, FCRL3, DUSP6, MDFIC, BANK1, IL1B, KIT, TLR6, PLCB1, TLR4, CCL13, CXCR4, GNAI2, PAK1, GPNMB, NTF3, CCL19, CCL18, CD74, CCL23, CCL21, CCL20, CARD9, CD40LG, PKN1, TNF, CTGF, PYCARD, PDGFRB, PDGFRA, MAP2K2, IGFBP3, F2R, ADCYAP1, ADAM9, ADAM8, CSF1R, C5AR1, TNFRSF11A, ADRB2, RASGRP1, PSAP, DRD4, MAP2K6, TGFB2, TGFB1, CAV2, GH1, IL6, BMP2, CDK1, CSPG4, LRRK2, TREM2, PTPN22, GHR, XCL2, CHI3L1, XCL1, PDE5A, NOD2, THBS1, CCL8, CCL7, CCL5, CCL4, CCL2, CCL1, CSK, EGF, TIE1, MAPK14, CD4, LTBR, TEK, FCGR2B]
GO:0001782;B cell homeostasis;7.0;0.9326813400603323;0.8172600352873667;9.510741216835738;22.00128503895464;6.599019797332524;7.363632103827933E-4;0.6883935445785896;[LYN, MEF2C, TNFRSF13B, TNFAIP3, TNFSF13B, BCL2, NCKAP1L, PKN1]
GO:0050861;positive regulation of B cell receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;365.0896954818653;7.8311634786251565;0.01221922354838398;0.7754860644832351;[LYN, PRKCH, NFAM1, STAP1]
GO:0051279;regulation of release of sequestered calcium ion into cytosol;9.0;0.7369933605727446;0.7647373054666613;9.242861771680136;148.50473241193134;5.486614186532078;0.004970319748245178;0.676826329833192;[CXCL9, CAMK2D, THY1, CORO1A, SLC8A1, JPH2, PLN, CD19, DMD, PLCG1, SNCA, LYN, TGFB1, TRPC1, PRKCE, F2R, CXCL10, CXCL11, FKBP1B, XCL1, PTPN6, CALM3, F2RL3]
GO:0001774;microglial cell activation;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;31.19674186509269;6.8867018697843045;0.001044126874979773;0.6753065664753021;[CX3CR1, IL33, JUN, ITGAM, ITGB2, FPR2, AZU1, CLU, TLR8, TLR7, TLR6, TLR2, SNCA]
GO:0071300;cellular response to retinoic acid;6.0;1.0;0.8231203125901445;9.628524252492122;200.602279209425;5.54296712308321;0.006713977754809188;0.606587909038952;[LYN, ABCA1, YAP1, TNC, KLF4, PHB2, PAX2, AQP1, COL1A1, MYB, RARA, HOXA2, EPHA3]
GO:0010803;regulation of tumor necrosis factor-mediated signaling pathway;7.0;0.8933024483968273;0.7975705894556142;9.446202695698167;58.00234281560482;5.734022359845919;0.001941286215318787;0.64415753539903;[TNFAIP3, TNF, PYCARD, CHUK, SYK, NR1H4, TRAF1, BIRC3]
GO:0032930;positive regulation of superoxide anion generation;8.0;1.0;0.875;9.628524252492122;144.57516735605006;7.004484905440688;0.00483880074220378;0.7332096838060964;[TGFB1, ITGAM, PRKCD, ITGB2, FPR2, GNAI2, CD177]
GO:1902475;L-alpha-amino acid transmembrane transport;10.0;0.6181399273706679;0.7243109755462542;8.529911963824013;268.42115299878213;6.063501560976162;0.00898381442751516;0.7253287636709003;[SLC38A1, SLC43A2, SLC1A3, SLC7A11, SLC1A6, SLC7A5, SLC7A7, SLC7A8, SLC17A6]
GO:1903206;negative regulation of hydrogen peroxide-induced cell death;9.0;0.8436909121759173;0.8180860812682478;9.589303539338841;500.078557460717;6.8867018697843045;0.01673717927672765;0.7484268790654467;[IL10, GPR37, LRRK2, NR4A3, PSAP]
GO:0038195;urokinase plasminogen activator signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;9.083926447120524;8.87013979980389E-4;0.7876727335416686;[PLAUR]
GO:0043388;positive regulation of DNA binding;5.0;0.7090535922965819;0.6447678080092112;8.578702127993445;32.525455185636034;5.825829909099042;0.0010885977140540058;0.5881742243410422;[HMGB2, TWIST1, GATA3, MYOCD, TGFB1, EGF, PLAUR, KLF4, MMP9, POU4F1, NME1, IFNG]
GO:0042730;fibrinolysis;9.0;1.0;0.896240625180289;9.628524252492122;252.8988266382142;6.7325511899570465;0.008464296133413719;0.740543606130341;[SERPINB2, PLAU, PROS1, SERPINE1, PLAUR, SERPING1, GP1BA]
GO:0023014;signal transduction by protein phosphorylation;8.0;0.7248374789738407;0.7374187394869203;9.153100555777048;203.92357026499027;3.9689311377000256;0.006825138377471068;0.5779713229561524;[, IL5RA, TNF, FGF5, TNFSF11, KCNH1, MEN1, PDGFRB, MEF2A, KCNH2, PDGFRA, MED1, MEF2C, MAP2K2, PAQR3, EREG, BTC, TRIB1, PDGFA, CSF2RB, IQGAP3, CSF2RA, RASGRP1, RASGRP4, SPTA1, MAP2K6, LYN, TGFB1, PTK2, NFKB1, LAT, LRRK2, CTSH, CCR5, SPTAN1, JAK3, MAP4K1, CHUK, STRADB, IL18, GFRA3, DUSP6, IL1B, KIT, IL3RA, SHANK3, HBEGF, CAMK2D, NOD2, IL2RG, PAK1, CCL5, CCL2, NCAM1, FYN, EGF, MAPK14, MAPK13, KITLG, IL2RB, TEK]
GO:0002554;serotonin secretion by platelet;10.0;1.0;0.9152410118609203;9.628524252492122;131.6544252072528;8.67846133901236;0.0044063551303965215;0.8590579283277371;[FCER1G, SYK, P2RX1]
GO:0043270;positive regulation of ion transport;6.0;0.5280135766324326;0.5871271009063608;7.175366301018702;46.28499923684045;4.288135901523783;0.00154911727066213;0.5424157820127834;[CHRM1, ATP8A1, MYLK, LGALS3, AKT1, TNFSF11, EPHB2, PDGFRB, KCNH2, F2R, PRKCD, ACTN4, ATP1B2, MIF, PDZK1, KMO, ATP1B1, KCNQ1, CFTR, KCNE3, ABCB4, TNFRSF11A, ADRB2, THY1, TMEM27, CD19, PLCG1, DRD4, MAP2K6, CCR1, WFS1, CYP4F2, CAV1, CXCL10, CXCL11, EHD3, CXCL12, CALM3, CXCL9, CTSS, JPH2, EDN1, TRPC3, TRPC1, CYP4A11, AVPR1A, DNM2, IL1B, XCL1, SHANK3, PTAFR, CCL5, CCL4, FLNA, CCL2, DMD, SNCA, P2RX5, CD4, P2RX1, F2RL3]
GO:0098655;cation transmembrane transport;6.0;0.518007056267642;0.5821238407239655;7.133254815668575;43.36096628843346;3.3345334612122706;0.0014512525193377528;0.4936485088682041;[PHB2, AQP1, SCN1A, SLC6A16, SLC11A1, SLC6A15, PRKCE, CACNA2D3, SLC6A13, SLC6A12, COX7A2L, KCNQ1, SLC22A4, SLC22A2, ATP5J, ATP5I, ATP5H, SLC30A10, ATP5O, ATP5L, KCNMB3, KCNN3, SCN3A, SLC6A6, FXYD2, COX7B, COX7C, JPH2, CCR7, CCR5, COX8A, KCND2, ZDHHC17, TMEM37, CAPS2, KCNA5, COX5B, COX5A, CCL19, SLC17A1, SLC17A3, CCL21, SLC31A2, COX6C, FKBP1B, RHAG, KCNG2, STEAP3, STEAP4, DENND5B, COX6A1, SLC8A1, KCNH1, KCNH2, F2R, ATP1B2, ATP1B1, ATP5J2, COX6B1, RHCE, KCNE3, CUL5, KCNE4, HVCN1, SLC41A2, SLC1A3, ITPR3, CACNA1F, CYC1, SLC15A3, PTPRC, KCNK5, ATP2A3, SLC40A1, FASLG, ATP7B, SLC36A1, TRPC7, SLC13A1, TRPC3, TRPC1, NDUFS7, LCK, XCL1, SLC24A2, SLC24A1, SLC24A4, ATP2C2, SLC5A10, SLC12A2, NDUFA4, SLC12A1, KCNJ15, KCNJ16, P2RX5, P2RX1]
GO:0010976;positive regulation of neuron projection development;9.0;0.6763753087927167;0.7344282795766475;9.14017148457819;493.1928131726474;4.231896183200907;0.016506719612173492;0.6126599927924817;[SCARB2, CYFIP1, CPNE5, PLXND1, FMR1, ARHGDIA, ADCYAP1, MAP1B, EPHA3, LYN, FZD1, SYT2, FN1, CXCL12, FES, PLXNB2, EZH2, ROBO2, NRP1, NME1, SHANK3, NLGN1, RAB21, PAK1, CNR1, FYN, FKBP1B, CAMK1]
GO:0032760;positive regulation of tumor necrosis factor production;7.0;0.8933024483968273;0.7975705894556142;9.461470167828956;85.9095484537234;5.587418885654044;0.002875315273172136;0.6366602269110988;[ORM1, LRRK2, CLU, PYCARD, IFIH1, CD36, CCR2, HAVCR2, FCER1G, DDX58, MIF, TLR1, IL23A, TLR4, TLR2, PTAFR, LY96, TWIST1, NOD2, THBS1, RASGRP1, CCL19, CD14, FZD5, CARD9, AZU1, CD2, PF4]
GO:0006919;activation of cysteine-type endopeptidase activity involved in apoptotic process;13.0;0.9326813400603323;0.9288956347978027;9.604426700913061;734.4853933519539;5.322726331426962;0.024582565121551242;0.7347594368888992;[FASLG, TNF, PYCARD, CTSH, F2R, F3, IFI27, LCK, S100A8, NLRC4, HSPD1, NLRP3, SNCA, CASP8AP2, TNFRSF10B, HSPE1, PML, NLRP12, P2RX1, DLC1]
GO:0032765;positive regulation of mast cell cytokine production;9.0;1.0;0.896240625180289;9.628524252492122;311.82526325162985;8.67846133901236;0.010436510936514811;0.8400575416471059;[FCER1G, NR4A3]
GO:0060397;JAK-STAT cascade involved in growth hormone signaling pathway;8.0;1.0;0.875;9.628524252492122;26.42836680105094;7.212124270218933;8.845336528452411E-4;0.7438283705770736;[LYN, GHR, GH1, PRL, JAK3]
GO:0090025;regulation of monocyte chemotaxis;9.0;0.8933024483968273;0.8428918493787028;9.510741216835738;137.5287080193099;6.641579411751319;0.004602962089604771;0.7358913051622797;[LYN, CCR1, GREM1, CXCL10, CXCL12, CCL5, SERPINE1, CCL1, FPR2, S100A14, PLA2G7, CCR2]
GO:0035590;purinergic nucleotide receptor signaling pathway;7.0;0.9326813400603323;0.8172600352873667;9.510741216835738;27.195621953761602;6.641579411751319;9.102129923216596E-4;0.6905700452391912;[P2RY13, P2RY14, GPR87, PTAFR, P2RX5, P2RY6, P2RY2, P2RX1, GPR171]
GO:0034144;negative regulation of toll-like receptor 4 signaling pathway;9.0;1.0;0.896240625180289;9.628524252492122;354.70667396235325;7.697632086000634;0.011871713162238609;0.7898978880348613;[LYN, TNFAIP3]
GO:0034142;toll-like receptor 4 signaling pathway;12.0;0.8436909121759173;0.8699657686781033;9.485423408851448;412.6549923027037;6.943860283624253;0.013811191226989502;0.8032296504172152;[ITGAM, PRKCE, ITGB2, NR1H4, LY96, NFKBIA, S100A14, CD14, TLR4]
GO:0043277;apoptotic cell clearance;7.0;1.0;0.8509193652572005;9.628524252492122;28.437470009997963;6.8867018697843045;9.517765291732001E-4;0.7031056191423581;[LRP1, ITGB3, MARCO, RARA, CD36]
GO:0000821;regulation of arginine metabolic process;8.0;0.7763722522362496;0.7631861261181248;9.303101852057495;103.95066091928724;9.083926447120524;0.003479135071447466;0.839552420951524;[SLC7A7]
GO:0038063;collagen-activated tyrosine kinase receptor signaling pathway;8.0;1.0;0.875;9.628524252492122;57.50475921673876;7.474488534686424;0.0019246325400609058;0.7572456912631272;[COL1A1, SYK, COL4A2, COL4A1]
GO:0042742;defense response to bacterium;6.0;0.7866048967936545;0.7164227609869718;9.193206181234276;69.6526388451159;4.021331414093558;0.0023312111388408135;0.5287713881179241;[, SERPINE1, HP, CXCL13, TNF, MPO, PYCARD, IGHG1, TRBC1, IL6R, SLC11A1, PRKCD, RNASE6, RNASE3, CLEC4D, SLPI, IL23A, S100A8, SEH1L, C5AR1, KLRK1, NLRP3, S100A12, S100A14, IGHA1, ELANE, DEFA4, PRG2, ISG15, AZU1, DEFA1, PPBP, LYZ, SELP, IL6, BCL3, IGKV3-20, MYD88, IGHM, CXCL6, HMGB2, GNLY, STAB1, CTSG, CD36, CAMP, HAVCR2, IL10, FCER1G, SYK, ANXA3, TLR1, FGR, IGHD, LTA, BPI, TLR6, TLR5, TLR4, LTF, TLR2, CEBPB, CEBPE, HIST1H2BK, NLRC4, NOD2, IGKC, CCL20, CARD9, NR1H4, CD4]
GO:0045579;positive regulation of B cell differentiation;9.0;0.8436909121759173;0.8180860812682478;9.503361109538115;803.2041625246294;7.212124270218933;0.026882520482883615;0.7650689957573628;[SYK, INPP5D, BTK, ATP11C, CD27, NCKAP1L]
GO:0072011;glomerular endothelium development;8.0;0.9326813400603323;0.8413406700301662;9.523163736834295;41.716971210279375;8.67846133901236;0.0013962294835714489;0.8188169164668168;[PECAM1, CD34]
GO:0031668;cellular response to extracellular stimulus;4.0;0.5452700253111464;0.5226350126555732;7.377232453885626;45.163559484697416;4.334655917158676;0.0015115836913881548;0.47167450518560927;[EHMT2, TNC, SESN3, LAMP2, SKP2, POSTN, SFRP2, RRAGD, SIK1, ATF3, SEH1L, ABCB4, FOXO1, HMOX1, GAS2L1, LYN, JUN, EIF2S1, NR4A2, COL1A1, BCL2, CDKN1A, PLEKHF1, LRRK2, KRT20, ASGR1, UPP1, AVPR1A, FOS, SIRT1, AES, PTGS2, FYN, NR1H4, SIPA1, FOXA3, FOXA2]
GO:0030218;erythrocyte differentiation;5.0;0.8436909121759173;0.712086467948879;9.117698628726131;22.675663695230284;5.885253329569843;7.589340571069517E-4;0.5912131408273906;[ALAS2, SPI1, GATA3, IKZF1, GATA1, AHSP, JAK3, LYN, INHBA, KLF1, TGFBR3, KIT, ACIN1, TRIM10]
GO:0072378;blood coagulation, fibrin clot formation;6.0;1.0;0.8231203125901445;9.628524252492122;55.78978942234946;8.16763571524637;0.0018672340444153065;0.7408135829017477;[F13A1, FBLN1]
GO:0044130;negative regulation of growth of symbiont in host;7.0;1.0;0.8509193652572005;9.628524252492122;102.69207226600344;7.212124270218933;0.0034370112418783067;0.7197477358342742;[IL10, LTA, CTSG, CD36, TNF, MPO, ELANE]
GO:0010628;positive regulation of gene expression;6.0;0.4705935272257725;0.5584170762030307;6.666693530613812;58.797024432214236;2.2471302570788807;0.001967883493859682;0.43803865843940215;[PID1, SPI1, SPIB, AKT1, MEF2A, MEF2C, PADI2, ATF3, GATA3, IQGAP3, GATA1, C3, JUN, JAG1, JUP, FN1, AZU1, NR2F2, COL1A1, LRRC32, HOXC10, FOS, SIRT1, MMP12, PLSCR1, CKS2, PTAFR, STAT4, SPP1, ATAD2, PSMC6, PSMC2, LGR4, CCNT2, RORA, CTGF, RUVBL2, ADCYAP1, PKP3, BLM, FOXO1, ZNF423, NFKB1, NFKB2, CXCL10, MYD88, CIITA, FHL2, PIK3CD, HHEX, ITGB8, PPP1R12A, PEG3, PPP1R15A, CCL5, E2F1, E2F2, E2F5, E2F7, PRRX1, POU2AF1, EIF3E, EIF3D, CCNH, IKZF1, TNFSF11, EPHB2, HNF1B, SFRP4, SFRP2, EGR1, EGR2, EGR3, ID1, CD28, CD40, HNF4G, BRCA1, BRCA2, CD3E, CD3D, HNF4A, CTSH, CD38, CD36, CD34, IL10, IL18, RGMA, IL1A, IL1B, KIT, YAP1, SATB2, CD74, IL33, FOXA3, IL17A, FOXA2, CD86, CD80, IHH, ETS1, ACTG2, EOMES, CCNE1, CCNB1, VDR, CAV1, HMGA1, INHBA, IL6, BMP2, NAT8, TCF4, IL7R, HMGB2, ARHGEF10L, LYL1, NUP62, MYBL1, YWHAH, MYOCD, DDX58, ETV1, ACTA2, CCNA2, GREM1, PSRC1, ELF3, IRF7, CREB5, TAF9, TBX21, RBM38, EGF, MAPK14, CD4, NAA15, RAN, EHF, SERPINE1, MYB, HOXA3, HOXA2, HOXA7, JUNB, HOXA5, MED1, HOXB9, HOXB4, HOXB3, HOXB2, MAML3, HOXB7, HOXB5, NUP85, PRDM16, NKX2-3, FZD1, NFE2, FZD5, FZD8, UPF3B, TGFB1I1, PAWR, SERPINB9, PAX5, PAX2, RARA, PLCB1, ENG, NR1I2, FAM129A, EPCAM, GSN, NR1H2, NR1H4, GTF2H1, POU4F1, PLP1, FOSB, PF4, PLXND1, FMR1, TNC, TNF, CLU, CDH3, CDH1, LAMP3, MEN1, MAP2K2, F2R, ADAM2, ADAM8, DAB2, COPS5, MAFF, BCL3, CDK1, PTPN22, CYR61, LBH, EMILIN1, RFC1, CHUK, TFDP1, CEBPB, SMARCD3, CEBPE, NOD2, ABLIM3, POLR2E, POLR2K, POLR2L, KLF4, PML, KLF1, KLF6, KLF5, CHEK1, RPS6KA1, DPF3, SOX7, SOX4, SLC11A1, EBF1, FLT3LG, RUNX2, NIF3L1, IL23A, BEX1, TXK, TWIST1, NHLH2, BCL11B, LIF, TOP2A, IFNA2, PRL, EPB41L4B, EDN1, RHOG, PARP9, MDFIC, TFEC, TLR6, TLR4, TLR2, CDX2, CDX1, LILRB1, GRHL2, CAMK4, CAMK1, ARID4A, ARID4B, HOXA11, HOXA10, HGS, ADRB2, STAP1, NLRP3, TGFB2, TGFB1, NR4A2, NFKBIA, NR4A1, LIN28A, NR4A3, FEV, SLC40A1, KLF13, CKAP2, AXIN2, DCN, DNM2, IFNG, LEF1, DLL1, THBS1, LUM, MEIS2, MEIS1, RBMX]
GO:0010506;regulation of autophagy;6.0;0.6260725219892441;0.6361565735847665;8.273978589686811;43.35793677134884;4.08334148887777;0.001451151124127319;0.5319425862261522;[AKT1, DAPK1, RRAGD, HMOX1, FZD5, PLK2, PTK2, SIRT1, RAB33B, NEDD4, SESN3, LAMP3, TSC2, ADRB2, FOXO1, PSAP, OSBPL7, BCL2, PLEKHF1, LRRK2, PTPN22, DCN, IFNG, DRAM1, SNCA]
GO:0031663;lipopolysaccharide-mediated signaling pathway;6.0;1.0;0.8231203125901445;9.628524252492122;26.50247477320489;6.343086423195323;8.87013979980389E-4;0.647506047256038;[PTAFR, LY96, PTPN22, TNF, CCL5, AKT1, CCL2, CD14, LYN, TGFB1, PRKCE, IL18, MAPK14, NFKBIA, HCK, CD6, IL1B, TLR4, TLR2]
GO:0034136;negative regulation of toll-like receptor 2 signaling pathway;9.0;1.0;0.896240625180289;9.628524252492122;354.70667396235325;8.390779266560578;0.011871713162238609;0.8253454670833372;[LYN, TNFAIP3, TLR6]
GO:0010744;positive regulation of macrophage derived foam cell differentiation;6.0;1.0;0.8231203125901445;9.628524252492122;113.85781812010546;7.004484905440688;0.0038107187070962377;0.6813299963962409;[MSR1, PRKCH, AGTR1, IL18, CD36, NFKB1, PF4]
GO:0032755;positive regulation of interleukin-6 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;64.94897299966192;5.395046993006588;0.0021737836760178982;0.5990232667078439;[IL1RN, TNF, PYCARD, IFIH1, CD36, IL6R, FCER1G, DDX58, F2R, EREG, TLR1, ADCYAP1, IL1A, IL1B, TLR8, TLR7, TLR6, TLR4, TLR2, PTAFR, TWIST1, NOD2, HSPD1, IL33, CARD9, LILRB2, MAPK13, IL6, MYD88, IL17A]
GO:0018105;peptidyl-serine phosphorylation;9.0;0.7369933605727446;0.7647373054666613;9.207310787415818;338.73676479787366;4.61801832846594;0.011337214674488616;0.6324062972578516;[, AKT1, STK32B, MAP2K2, PRKCH, PRKCE, PRKCD, VRK1, PRKCQ, PRKCZ, CCNB1, PLK2, PLK1, CLK1, CDK1, BCL2, LRRK2, MAP4K1, CHUK, SYK, SGK1, CAMK2D, AURKB, MAPK14, MAPK13, CAMK4, PKN1, CAMK1]
GO:0071726;cellular response to diacyl bacterial lipopeptide;8.0;1.0;0.875;9.628524252492122;168.80270344913424;8.390779266560578;0.005649674571872418;0.8041048419030481;[CD36, TLR6, CD14, TLR2]
GO:0030335;positive regulation of cell migration;7.0;0.5846489169746516;0.6432438237445264;8.22453031427283;157.26390226612122;3.6656062881777913;0.005263481280523835;0.5383786413027378;[SPARC, SERPINE1, MYLK, LGALS3, C3AR1, AKT1, IL1R1, PRKCE, ACTN4, IL23A, PFN1, PDGFA, FPR2, GATA3, THY1, PLA2G7, EPB41L5, PDGFD, PDGFC, HMOX1, NCKAP1L, S100A14, PLCG1, ELANE, LYN, CCR1, JUN, TNFSF14, PLK2, FN1, PPBP, PTK2, COL1A1, NOX4, SNAI2, NRP1, NRP2, CD40, EPB41L4B, RAC2, CTSH, CCR7, CCR6, CCR2, EDN1, ANXA1, ANXA3, GAB1, SIRT1, F3, IL1A, CEACAM6, IL1B, KIT, HBEGF, PTAFR, PTGS2, GNAI2, PAK1, GPNMB, CXCR2, PDPN, NTF3, FLNA, CCL19, CD74, CCL21, CCL20, PF4, SEMA5B, ATP8A1, ITGA2B, CXCL13, TNF, ETS1, SLC8A1, CXCL16, PYCARD, PLAU, IL6R, PDGFRB, PDGFRA, POSTN, SEMA6A, IGFBP5, F2R, ADAM9, ADAM8, CD274, CSF1R, CD151, C5AR1, CORO1A, TGFB2, TGFB1, SELP, VIL1, CXCL10, CXCL11, IL6, BMP2, DAB2, CXCL12, PTPRC, NR4A3, BCL2, DOCK5, CXCL6, CXCL9, DOCK4, TNFAIP6, ITGB3, PIK3CD, LAMC2, CXCL1, CXCL3, CXCL2, CXCL5, CYR61, ITGA4, MMP9, FGR, IFNG, XCL2, XCL1, LEF1, THBS1, P2RY6, CCL8, CCL7, CCL5, CCL4, CCL1, EGF, SEMA4B, LAMB1, MAPK14, SOD2, TEK]
GO:0090237;regulation of arachidonic acid secretion;9.0;0.8933024483968273;0.8428918493787028;9.485423408851448;83.13942816732954;7.9853141584524145;0.0027826018401329354;0.8046099625986299;[SYK, MIF]
GO:0045588;positive regulation of gamma-delta T cell differentiation;10.0;1.0;0.9152410118609203;9.628524252492122;1283.265958453736;8.67846133901236;0.04294975676506408;0.8590579283277371;[SYK, NCKAP1L]
GO:0060742;epithelial cell differentiation involved in prostate gland development;5.0;0.8653626801206646;0.7229223519212526;9.310070521373587;43.82069192109257;7.474488534686424;0.0014666391225366452;0.6724867031240476;[PSAP]
GO:0002774;Fc receptor mediated inhibitory signaling pathway;8.0;1.0;0.875;9.628524252492122;130.16139686502353;8.67846133901236;0.004356384815420379;0.8188169164668168;[LYN, LILRB1, LILRB2]
GO:0000122;negative regulation of transcription by RNA polymerase II;11.0;0.6073376606709605;0.7360977826651425;8.793202583151634;1836.9481969605868;3.0544438328250214;0.0614810030062249;0.5886333519864981;[SPI1, EHMT2, SLA2, MYB, HOXA2, HOXA7, JUNB, MEF2A, MED1, MEF2C, HOXB4, HOXB3, ATF3, GATA3, GATA1, PRDM16, HESX1, ELANE, JUN, PLK1, FZD8, NR2F2, SNAI2, PKIG, EZH2, BTG2, PAWR, PAX5, SIRT1, AES, MMP12, RARA, ASCL2, NR1H2, NR1H4, POU4F1, FOSB, TNF, DACH1, MEN1, TLE4, AEBP1, FOXO1, NACC2, WFS1, NFKB1, NFKB2, BCL6, CIITA, FHL2, FASLG, HHEX, RFC1, PEG3, CEBPB, RBBP8, E2F1, E2F7, PRRX1, KLF4, KLF8, KLF5, DNAJA3, UXT, ZNF608, EDNRB, SOX7, SOX4, HNF1B, IFI27, TWIST1, PCBP3, EGR1, BCL11A, ID1, SUV39H1, BMI1, XPO1, CD36, EDN1, PARP9, IL1B, SATB2, CDX2, NEDD4, LOXL2, CHCHD3, EOMES, CCNE1, TCF7, TGFB1, CBX4, VDR, CAV1, NR4A2, BMP2, NR4A3, MXD1, MYOCD, KLF12, IFNG, IRF7, FBP1, LEF1, AURKB, TBX21, SNCA, MEIS2]
GO:0032868;response to insulin;7.0;0.9326813400603323;0.8172600352873667;9.541512875502493;74.03337757263446;4.800339885259895;0.0024778305216419678;0.5964089702280253;[CYFIP1, ADM, SESN3, AKT1, IL10, GHSR, CAD, SIRT1, CEACAM1, TLR2, RETN, FOXO1, PAK1, PLN, LYN, EGR1, EGR2, SORT1, SORBS1]
GO:0010951;negative regulation of endopeptidase activity;10.0;0.7671156992804218;0.7987988615011312;9.446202695698167;500.3238742612354;4.2676852910524925;0.016745389809270216;0.6334906361130068;[PROS1, SERPINE1, SPINT2, AQP1, LAMP3, RPS6KA1, AKT1, APLP2, POR, SFRP2, SPINT1, SLPI, SERPING1, NAIP, C3, SFN, A2M, TNFSF14, TNFRSF10C, CRIM1, TNFRSF10B, DHCR24, VIL1, CD27, TNFAIP8, SERPINA1, TIMP2, TIMP3, TIMP1, CR1, SERPINB2, PLAUR, SERPINB9, TNFRSF1B, MMP9, PAX2, COL6A3, BIRC5, LTF, BIRC3, SERPINB10, LEF1, IFI6, NLRC4, PTGS2, CST7, THBS1, CST3, SPOCK3, SNCA, KLF4, FABP1]
GO:0070543;response to linoleic acid;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;46.1874048850311;9.083926447120524;0.0015458508755362855;0.7876727335416686;[CD36]
GO:0070304;positive regulation of stress-activated protein kinase signaling cascade;8.0;0.7866048967936545;0.7683024483968273;9.394909401310617;268.25740884697916;4.746635706288034;0.008978334058114483;0.6177431707607042;[IL1RN, TNF, CTGF, PYCARD, TNFSF11, CCR7, MAP4K1, EDN1, SYK, MDFIC, IL1B, TLR6, PLCB1, TNFRSF11A, NOD2, RASGRP1, PAK1, CCL19, SLAMF1, LYN, TGFB2, FZD5, CCL21, CARD9, FZD8, BMP2, CD40LG, CD27, PKN1, LTBR, FCGR2B, NOX1]
GO:0070667;negative regulation of mast cell proliferation;7.0;1.0;0.8509193652572005;9.628524252492122;83.65590509736859;9.777073627680469;0.0027998878581822827;0.8509193652572005;[LYN]
GO:0070668;positive regulation of mast cell proliferation;7.0;1.0;0.8509193652572005;9.628524252492122;83.5280859103553;9.777073627680469;0.002795609865022748;0.8509193652572005;[LYN]
GO:2000334;positive regulation of blood microparticle formation;6.0;0.9326813400603323;0.7894609826203107;9.548481544818586;107.44151918580685;9.083926447120524;0.0035959709560594052;0.7876727335416686;[CD36, TNF]
GO:1900086;positive regulation of peptidyl-tyrosine autophosphorylation;11.0;1.0;0.9324289523296623;9.628524252492122;1786.9389585583017;8.16763571524637;0.05980723880229299;0.8501222226412654;[GREM1, ACE, SYK]
GO:0034121;regulation of toll-like receptor signaling pathway;7.0;0.609056648853049;0.655447689683725;8.322272599045768;87.36499042264505;5.666199763507158;0.002924027606059212;0.6406890846681925;[LY96, TNFAIP3, PTPN22, CD36, CD14, LYN, RSAD2, FCRL3, CAV1, IRAK3, TLR1, IRF7, TLR6, TLR5, TLR4, LGR4, LTF, TLR2, BIRC3]
GO:0050707;regulation of cytokine secretion;8.0;0.5887823193610073;0.6693911596805037;8.358061706897352;114.42085987655861;4.647174912757396;0.003829563207980042;0.6126567411541474;[TNF, PYCARD, CLEC5A, GHSR, POSTN, IL1R2, F2R, MIF, CD274, CSF1R, TWIST1, GATA3, PRKCZ, RASGRP1, NLRP3, CD14, LYN, FZD5, CRTAM, FN1, ORM1, LRRK2, IFNA2, PTPN22, LRRC32, IFIH1, FFAR2, CCR7, CD34, HAVCR2, IL10, ANXA1, CHUK, SYK, DDX58, IL17RB, MMP12, TLR1, FGR, IL1A, BANK1, IL1B, IGHD, TLR8, TLR10, TLR6, TLR5, TLR4, TLR2, NOD2, CD58, CCL19, IL33, NR1H4, LILRB1, MAPK14, PML, CD2, NLRP12, FCGR2B, LGR4, CD244, IL17A]
GO:0009743;response to carbohydrate;4.0;0.6347111282356054;0.5673555641178027;8.102467948997072;27.321196622860832;4.720827822332161;9.144158634865458E-4;0.49142335437501145;[SPARC, SLC8A1, CTGF, LGALS1, HNF4A, SOX4, MEN1, RMI1, HNF1B, PAX2, NME1, IL1B, COL6A2, CALCRL, PTGS2, THBS1, CST3, MAP2K6, LYN, EGR1, EIF2B3, TGFB1, MAPK13, LIN28A, FKBP1B, NOX4]
GO:0007320;insemination;3.0;1.0;0.6981203125901445;9.628524252492122;44.01483730457378;8.390779266560578;0.00147313699380226;0.6272251544931927;[P2RX1]
GO:0060736;prostate gland growth;4.0;0.8653626801206646;0.6826813400603323;9.405380701177911;43.8113314783287;7.474488534686424;0.00146632583694119;0.6322456912631272;[PSAP]
GO:0002431;Fc receptor mediated stimulatory signaling pathway;9.0;0.8933024483968273;0.8428918493787028;9.533214072687796;218.73839564357212;4.87179884924204;0.007320977250414979;0.6453846448923425;[CYFIP1, CD3G, IGHG1, FCGR3A, FCER1G, SYK, PRKCE, PRKCD, VAV1, FGR, HCK, PAK1, IGKC, IGLV1-44, NCKAP1L, FYN, PLCG1, LYN, PTK2, FCGR2A, NR4A3, CD247, FCGR2B, IGKV3-20]
GO:0002553;histamine secretion by mast cell;10.0;1.0;0.9152410118609203;9.628524252492122;188.83492405524427;8.67846133901236;0.006320134967730841;0.8590579283277371;[LYN, BTK]
GO:0007204;positive regulation of cytosolic calcium ion concentration;11.0;0.6835726970475526;0.7742153008534385;9.097896001429952;290.3013502407617;4.174954806800768;0.00971612493830514;0.645936335304707;[CXCL13, SLC8A1, EDNRA, EDNRB, CCRL2, C3AR1, PROK2, PTGDR, PDGFRA, PRKCE, F2R, ADCYAP1, AGTR1, CALCA, C5AR1, FPR1, FPR3, ITPR3, FPR2, THY1, CD19, HRH4, PLCG1, CCR10, CCR1, CAV1, CXCL10, CXCL11, PTPRC, CALM3, CD24, GPR18, CXCL9, FASLG, ADM, JPH2, CCR9, CD38, CCR7, CCR6, CD36, CCR5, CCR2, CD52, PTGIR, EDN1, TRPC3, GPR35, TRPC1, AVPR1A, LCK, IL1B, XCL1, CX3CR1, PTGER2, CXCR5, CXCR4, CXCR6, GNA15, CXCR1, CXCR3, CXCR2, S1PR3, CCL1, CCL19, GPR157, SNCA, CCL21, GPR6, P2RX5, CD4, FKBP1B, F2RL3]
GO:0030316;osteoclast differentiation;6.0;0.9326813400603323;0.7894609826203107;9.510741216835738;47.07409398820286;6.375876246018314;0.0015755275618510598;0.6491829203200885;[CSF1R, TGFB1, FCER1G, TFRC, TREM2, TNFRSF11A, GAB2, MAPK14, TNF, OSCAR, TYROBP, TNFSF11, JUNB, EPHA2]
GO:0032735;positive regulation of interleukin-12 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;6.311337724880743;0.002183412136085803;0.6458824173477649;[CD40, HSPD1, CCR7, CD36, CCL19, MAPK14, CD40LG, IFNG, IL23A, LTB, PLCB1, TLR4, TLR2]
GO:0043066;negative regulation of apoptotic process;7.0;0.5640623033008358;0.6329505169076184;7.792313020693233;81.07407142393629;2.9735683700721314;0.0027134762086319553;0.5029877899877601;[SERPINE1, PHB2, AKT1, PROK2, IER3, MED1, MEF2C, PRKCH, DAPK1, PRKCD, CLDN7, PRKCQ, GATA3, SLC30A10, GATA1, PRKCZ, FIGNL1, HMOX1, SFN, NCKAP1L, BARD1, JUN, PLK2, PLK1, AZU1, SNAI2, CDKN1A, BTG2, CHL1, TIMP1, JAK3, ANXA1, SERPINB2, DUSP1, ANXA5, SERPINB9, SIRT1, PAX2, RARA, PTGS2, UNG, NTF3, FLNA, CCL19, CCL21, GABRA5, NR1H4, POU4F1, FABP1, PF4, TNF, CLU, LAMP3, CLEC5A, F2R, ADCYAP1, MSH2, ADAM8, CSF1R, BLM, CORO1A, FOXO1, SOCS2, WFS1, TNFRSF10C, TNFRSF10B, DHCR24, NFKB1, DAB2, CXCL12, COPS5, BCL6, BCL3, CDK1, BCL2, MYD88, BCL2L1, LRRK2, FHL2, FASLG, CYR61, TNFRSF1B, ADAMTS20, BIRC5, BIRC3, CX3CR1, CEBPB, LRP1, NLRC4, NOD2, CCL5, CCL2, FYN, TIE1, KLF4, IL2RB, IL1RN, SLC46A2, IFIT3, AQP1, LGALS3, TCL1A, EDNRB, RPS6KA1, EPHB2, EPHB1, FLT3LG, HNF1B, MIF, BTC, POR, SFRP2, EPHA3, NAIP, EPHA2, TWIST1, PKHD1, EGR3, BCL11B, TNFSF14, PTK2, VNN1, ID1, CD28, CD27, NRP1, BRCA1, CTSH, CD38, CCR7, CCR5, IL10, EDN1, FCER1G, STRADB, HCK, RNF144B, IL1A, CEACAM6, IL1B, CEACAM5, KIT, YAP1, IFI6, GNAI2, CXCR2, PDPN, CTNNA1, CD74, LILRB1, CD40LG, GRINA, MAD2L1, IHH, MPO, COMP, ARHGDIA, PDGFRB, GHSR, PDGFRA, C5AR1, PSEN2, STIL, CBX4, CAV1, NR4A2, NFKBIA, VIL1, IL6, NR4A3, NAT8, IL7R, TNFAIP8, HMGB2, SLC40A1, TNFAIP3, NUP62, MYOCD, PLAUR, MMP9, GREM1, NDUFS3, IRF7, ZMYND11, LTF, BCL2A1, TAF9, LEF1, DLL1, THBS1, AURKB, HSPD1, SNCA, SOD2, TEK, NAA15]
GO:0006909;phagocytosis;6.0;0.9326813400603323;0.7894609826203107;9.4949928598676;28.437470009997963;5.618190544320798;9.517765291732001E-4;0.610434838299289;[NCF2, ITGB3, NCF4, ICAM3, ITGAL, CD36, ANXA1, CD93, ANXA3, SLC11A1, DNM2, PECAM1, RARA, PRTN3, CD302, LRP1, CEBPE, PLD4, CORO1A, CD14, ELANE, SLAMF1, MARCO]
GO:0033026;negative regulation of mast cell apoptotic process;9.0;1.0;0.896240625180289;9.628524252492122;301.33162323320204;9.777073627680469;0.010085298248760914;0.896240625180289;[FCER1G]
GO:0050702;interleukin-1 beta secretion;11.0;1.0;0.9324289523296623;9.628524252492122;137.76275822249997;7.697632086000634;0.004610795539274035;0.8260862151842345;[ABCA1, NLRC4, CD36, TLR6, TLR4]
GO:0032733;positive regulation of interleukin-10 production;6.0;0.8933024483968273;0.7697715367885581;9.427853557029971;65.23665507211369;6.375876246018314;0.002183412136085803;0.6491829203200885;[CD274, CD83, FCER1G, NOD2, PRKCZ, HSPD1, PYCARD, CD40LG, IL23A, BCL3, CD28, XCL1, TIGIT, TLR4, CD34, TLR2]
